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Abstract
Using the classical embryoid body approach, 3D aggregate cultures facilitate en-
hanced multi-lineage differentiation of pluripotent stem cells compared to 2D cul-
ture. However, such cellular aggregates can become necrotic over prolonged culture
in suspension reducing their ability to form complex tissues. We have developed
a two-stage 3D culture system whereby stem cells are grown first as aggregates in
suspension and then maintained as 3D constructs for extended periods on porous
polystyrene scaffolds. Combining 3D culture strategies in this way enhances the
formation of complex tissues by providing a suitable microenvironment and suffi-
cient time for developmental processes to occur. Differentiating pluripotent stem
cells forming complex tissues in vitro may provide an alternative to the current
gold standard teratoma formation pluripotency assay. Additionally, the role that
morphogens and small molecules play in development can be investigated using
this unique culture system, providing a novel approach to study aspects of human
embryonic development.
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1 Introduction
Pluripotent stem cells (PSCs) are defined by their ability to: (1) self-replicate indefi-
nitely in culture, and (2) produce differentiated derivatives of all three embryonic germ
layers (ectoderm, mesoderm, and endoderm) that are formed during development as a
result of gastrulation (Tam and Behringer, 1997; Smith, 2001). The first pluripotent
cell type to be identified, known as an embryonal carcinoma (EC) cell, was isolated
from murine teratocarcinomas—solid tumours containing differentiated tissues and un-
differentiated EC cells—in 1964 and shown to exhibit the two determining characteris-
tics of pluripotency (Kleinsmith and Pierce, 1964). Pioneering research with EC cells
led the way to the isolation of the iconic embryonic stem cell (ESC).
Murine ESCs (mESCs) were isolated in 1981 by explanting the inner cell mass (ICM)
of pre-implantation blastocysts. mESCs could be maintained in an undifferentiated
state in culture and produce differentiated derivatives of all three embryonic germ lay-
ers and certain extraembryonic lineages (Evans et al., 1981; Martin, 1981). In 1998,
human ESCs (hESCs) that shared many similarities with mESCs were derived from
human blastocysts (Thomson et al., 1998).
Induced PSCs (iPSCs) were generated in 2006 by retroviral transduction of murine em-
bryonic or adult fribroblasts with factors known to be required for pluripotency mainte-
nance during early embryonic development (Takahashi and Yamanaka, 2006). Expres-
sion of exogenous Oct4, Klf-4, Sox2, and c-Myc successfully generated murine iPSCs
that could be maintained in culture for extended periods and produced differentiated
tissues representative of all three germ layers. Shortly afterward, human iPSCs (hiP-
SCs) were generated using similar methods (Takahashi et al., 2007).
Recent advances have provided a deeper understanding of PSCs and their developmen-
tal origins. Epiblast stem cells (EpiSCs) and region-specific EpiSCs (rsEpiSCs) have
been isolated from post-implantation epiblast stage murine embryos and shown to be
equivalent to cells of the pluripotent ICM-derived epiblast that contributes to somatic
lineages but not extraembryonic structures (Brons et al., 2007; Tesar et al., 2007; Wu
et al., 2015). Both of these primed PSC types differ from naive mESCs and reflect bio-
logically distinct pluripotent states occurring in development (Figure 1).
PSCs—especially hiPSCs—have huge potential for regenerative medicine due to their
capacity to generate an array of differentiated cells and tissues that may be used for
transplantation therapies or for disease modelling and drug discovery (Murry and Keller,
2008). It will be interesting to see what advances in regenerative medicine result from
the increasing understanding of the biology of pluripotency.
Extensive characterisation of newly derived cell lines is vital in order to validate their
differentiation potential. Various methodologies for assessing cellular pluripotency have
been reported, including; in vitro characterisation, embryoid body (EB) formation, chi-
maera contribution, and teratoma formation (Mart´ı et al., 2013). Each of these meth-
ods has applications and limitations which will now be discussed.
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Figure 1: A schematic representation of distinct pluripotent stem cell populations.
Distinct pluripotent states occur during murine embryonic development and pluripo-
tent stem cells can be isolated at different stages. Embryonic stem cells (ESCs) are
isolated from the inner cell mass of pre-implantation blastocysts and can differentiate
to embryonic and extraembryonic lineages. Epiblast stem cells (EpiSCs) are derived
from explanted epiblast cultures and differentiate to epiblast-derived somatic lineages.
Region-specific EpiSCs (rsEpiSCs) correspond to a distinct posterior-proximal epiblast
population that can also differentiate to epiblast-derived somatic lineages. Figure taken
from Weissbein and Benvenisty (2015).
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1.1 In Vitro Culture
1.1.1 Assessing pluripotency
The first step in the characterisation of a newly derived cell line occurs in vitro. Mor-
phological characteristics such as small size and high nuclear:cytoplasmic ratio are typ-
ical of PSCs (Brons et al., 2007). Placental alkaline phosphatase (AP) is an enzyme
expressed in ESCs that can be detected through a colorimetric assay or immunohisto-
chemical techniques (Mart´ı et al., 2013).
Immunocytochemical staining is routinely used for the further characterisation of PSCs
in vitro via fluorescence microscopy and flow cytometry. Several markers specific for
pluripotency maintenance and ESC physiology are known and their expression in a
given cell is indicative of pluripotency (Mart´ı et al., 2013). Transcription factors in-
cluding Nanog (Chambers et al., 2003), Oct4 (Scholer et al., 1989), and Sox2 (Yuan
et al., 1995) are expressed in both mESCs and hESCs, while surface antigens including
TRA-1-60, TRA-1-80, SSEA-3, and SSEA-4 are associated with hESCs, and SSEA-1 is
expressed only on mESCs (Solter and Knowles, 1978; Mart´ı et al., 2013).
1.1.2 Pluripotency maintenance
A key facet of PSCs is that they replicate indefinitely in culture. There is considerable
cell type variation, however, in the conditions that are required to maintain stem cells
in an undifferentiated state.
EC cells have comparably low requirements in order to maintain their undifferentiated
state. Some EC lines, such as the human EC (hEC) line TERA2.cl.SP12, only needs
to be grown at high confluence using standard cell culture reagents in order to prevent
differentiation (Przyborski et al., 2004). ESCs are considerably more challenging to cul-
ture than EC cells and traditionally required feeder layers of mitotically inactivated
cells or conditioned media (Martin, 1981; Thomson et al., 1998).
Modern techniques allow mESCs to be cultured without feeder layers if supplied with
exogenous leukaemia inhibitory factor (LIF) and active bone morphogenetic protein
(BMP) signalling that can be provided by the addition of serum or recombinant BMP4
to the media (Williams et al., 1988; Ying et al., 2003). Later it was shown that cultur-
ing mESCs with chemical inhibitors of mitogen-activated protein kinase (to inhibit fi-
broblast growth factor signalling) and glycogen synthase kinase 3β (to activate Wnt/β-
catenin signalling)—known as 2i conditions—was sufficient to derive and maintain
germ-line competent mESCs serum-free without the addition of LIF or BMP (Ying
et al., 2008). This shed light on the ground state of mESC self renewal, indicating that
pluripotency maintenance required a block to differentiation rather than inductive sig-
nals.
hESCs on the other hand differ in their pluripotency mechanisms and require supple-
mentation with basic fibroblast growth factor (bFGF) and activin/nodal signalling—
known as F/A conditions—to maintain their undifferentiated state (Levenstein et al.,
2006; Brons et al., 2007). EpiSCs were derived from murine post-implantation epi-
blasts under F/A conditions—demonstrating their equivalence to hESCs—and undergo
rapid and effiecient spontaneous differentiation to all three embryonic germ layers that
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is indicative of their primed pluripotent state and has led to interest in their use as
a source for cell transplantation therapies (Brons et al., 2007; Wu et al., 2015; Najm
et al., 2011). EpiSCs are disctinct from mESCs in terms of genomic, epigenomic, and
metabolic profiles, clonogenicity, differentiation capacity, growth characteristics, and
culture conditions.
rsEpiSCs, however, were derived from explanted post-implantation epiblast exposed to
bFGF and IWR1 (an inhibitor of Wnt signalling)—known as F/R1 conditions—and are
generated from epiblast with a much higher efficiency than EpiSCs (Wu et al., 2015).
rsEpiSCs differ are distinct from EpiSCs in terms of their transcriptomic, epigenomic,
and metabolic profiles, their clonogenicity, tumorigenicity and chimaera contribution;
occupying a stabilised primed pluripotent state that corresponds specifically to the
posterior-proximal epiblast in vivo (Figure 1). It has been suggested that epiblast
patterning may demarcate cell populations corresponding to distinct regions in adult
organisms, although this remains to be determined (Wu et al., 2015).
Recent advances allow PSCs to be cultured feeder-free and in defined media. Defined
medium without the use of animal derived products such as serum is essential for dif-
ferentiation protocols to be reproducible and for the therapeutic potential of PSCs to
be realised (Murry and Keller, 2008).
1.1.3 Karyotypic stability
An important step in the in vitro characterisation of pluripotent stem cell lines is to
investigate their karyotypic stability over prolonged culture. Andrews et al. showed
that accumulated chromosome translocations acquired during hESC culture reduced
the requirements for maintaining pluripotency to a level more similar to hEC cells (An-
drews et al., 2005). Interestingly, the aneuploidy seen in long-term cultured hESCs
reflected chromosomal translocations seen in EC cells. EC cells will have been placed
under considerable selective pressure towards a self-maintenance phenotype during tu-
mour growth and similarly, faster growing ES cells will be selected for if cultured for
extended periods under suboptimal conditions (Andrews et al., 2005).
The karyotypic stability of a PSC line must be demonstrated in order for any therapeu-
tic applications to be realised. One study found that mESCs cultured beyond passage
14 were developmentally compromised (Nagy et al., 1993), highlighting the special care
required during PSC culture and the importance of this characterisation step.
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1.2 In Vivo Differentiation
In vivo techniques have traditionally been widely relied on to characterise the devel-
opment potential of newly derived stem cell lines because expression of pluripotency
markers alone in vitro is not sufficient confirmation of true pluripotency. Differentiation
in vivo supports cellular development through interactions with host tissues and PSCs
readily form complex tissues when cultured in vivo (Przyborski, 2005).
1.2.1 Chimaera contribution
Soon after the initial isolation of mESCs they were shown to produce functional germ-
line competent chimaeras (Bradley et al., 1984). Chimaera formation was assayed by
injecting mESCs into the ICM of a murine blastocyst which was then implanted into
the uterus of a pseudo-pregnant mouse. Implanted cells incorporated into all tissues in
the adult, including the germ cells, and therefore the pluripotency of mESCs could be
demonstrated unequivocally (Figure 2)(Bradley et al., 1984). Genetically labelled cells
or more simply, cells from a different pigmentation background have been used in order
to assess chimaera contribution phenotypically (Hall et al., 2009).
Functional germ-line chimaeras derived from cultured mESCs allowed knockout mice to
be generated meaning that gene modifications made to mESCs in vitro could be incor-
porated into an entire animal (Hall et al., 2009). Knockout mice are extremely power-
ful research tools for disease modelling and drug discovery as well as for studying gene
function in mammalian development.
Murine EC cells have also been shown to be able to contribute to normal development
in the embryo in certain cases (Andrews, 2002). Germ line transmission has never been
seen, however, indicative of the reduced developmental potential and malignant origins
of EC cells.
EpiSCs incorporate into the post-implantation epiblast and contribute to all three germ
layers but fail to incorporate into the pre-implantation ICM (Wu et al., 2015). rsEpiSCs,
however, only incorporate efficiently and contribute to all three germ layers when im-
planted into the posterior epiblast. EpiSCs and rsEpiSCs differ to mESCs in their abil-
ity to proliferate rapidly and generate large numbers of differentiated cells when incor-
porated into the post-implantation epiblast that is indicative of their primed pluripo-
tent state (Wu et al., 2015).
Strikingly, human region-specific PSCs (rsPSCs) derived from hESCs cultured under
F/R1 conditions were able to form heterospecific chimaeras when implanted into the
posterior epiblast of murine post-implantation embryos (Wu et al., 2015). This could
allow unprecedented access to early human embryonic developmental processes and
their study in vitro.
1.2.2 Tetraploid complementation
Tetraploid complementation is a more stringent pluripotency assay than chimaera con-
tribution and the pluripotency of mESCs has been further validated using this method.
Fusion of mouse morulae at the 2-cell stage generates a tetraploid embryo which is de-
velopmentally compromised (Nagy et al., 1993). When mESCs are fused with tetraploid
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Figure 2: Chimaera formation from diploid (2N) and tetraploid (4N) blastocysts.
A schematic representation of chimaera formation from diploid 2N blastocysts and
tetraploid (4N) blastocysts. To generate chimaeras, cultured mESCs are implanted into
the inner cell mass (ICM) of 2N murine blastocysts which are then implanted into the
uterus of a pseudo-pregnant mouse. Analysis of the chimaera that results can be used
to determine which tissues of the animal were derived from the implanted cells. If the
implanted cells were pluripotent then derivatives of all three embryonic germ layers and
germ cells will be able to be derived from them. Figure taken from (Obokata et al.,
2014).
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embryos, diploid cells outcompete the tetraploid component and the entire neonate pro-
duced is derived entirely from the injected diploid cells (Figure 2)(Nagy et al., 1993).
Tetraploid complementation has been used to confirm the pluripotency of both mESCs
and iPSCs of murine origin (Zhao et al., 2009).
Chimaera formation and tetraploid complementation are considered the gold standard
for assessing the potency of murine cells. In humans and non-human primates, how-
ever, chimaera formation is not possible for ethical reasons and the gold standard is
teratoma formation.
1.2.3 Teratoma formation
A qualifying criterion for the pluripotency of a stem cell line to be established is that
upon xenografting into immunocompromised animals a teratoma will form—a solid tu-
mour containing differentiating tissues representative of all three embryonic germ layers
(Andrews et al., 2001). It is well established that ESCs consistently form teratomas
containing differentiated tissues representative of all three germ layers when grown as a
xenograft in immunocompromised animals (Figure 3) (Martin, 1981; Thomson et al.,
1998; Przyborski, 2005).
Early xenograft experiments showed that isolated murine EC cells were capable of re-
generating an entire teratocarcinoma, confirming the notion that EC cells are the can-
cer stem cell origin of the tumours (Kleinsmith and Pierce, 1964). While some EC lines
do possess the ability to form teratomas containing derivatives of all three germ layers,
lineage-dependent differences exist.
Certain EC lineages, such as the hEC line TERA2.cl.SP12 display a propensity to form
teratomas containing primarily neural and non-neural epithelial tissues (Przyborski
et al., 2004). Moreover, some EC cell lines are incapable of differentiation without ex-
ogenous factors and thus considered nullipotent (Andrews, 2002). The limited differ-
entiation capacity of EC cells in vivo is further evidence of their malignant origin and
reduced developmental capacity in comparison to ESCs.
Particular clonal lineages of the first iPSCs failed to produce teratomas containing
derivatives of all three germ layers, likely the result of incomplete reprogramming (Taka-
hashi and Yamanaka, 2006). Since then, considerable research effort has refined the
reprogramming process and, more recently, iPSCs consistently produce teratomas con-
taining an array of differentiated tissues representative of all three germ layers (Taka-
hashi et al., 2007; Kimbrel and Lanza, 2015).
EpiSCs and rsEpiSCs both form teratomas containing an array of differentiated tis-
sues representative of all three embryonic germ layers, casting doubt on the hypothesis
that epiblast patterning could account for distinct body regions (Brons et al., 2007;
Tesar et al., 2007; Wu et al., 2015). Teratoma formation is slower and tumour volume
smaller in rsEpiSC teratomas, however, leading to interest in their use as a source for
cell transplantation therapies due to their reduced tumorigenicity (Weissbein and Ben-
venisty, 2015).
Teratoma formation is the gold standard pluripotency assay for newly derived human
stem cell lines and is an informative way to investigate the development potential of a
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Figure 3: Histological analysis of teratomas derived from hESCs.
The heterogeneous teratoma structure is shown in (A) and differentiated tissues shown
are intestinal wall (B), intestinal epithelial mucosa (C), smooth muscle (D), neural
ganglia (E), cartilage and bone (F), skin (G), respiratory tract epithelium (H), and
kidney tissue (I). Scale bars represent (A) 450 µm, (B,F) 150 µm, (C) 75 µm, (D, E,
I) 50 µm, (G) 40 µm, and (H) 15 µm. Figure taken from Przyborski (2005).
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given cell type. The technique has been criticised, however, due its lack of reliability
and high animal usage (Gropp et al., 2012). In depth histological analysis of teratomas
is required, as teratoma formation on its own does not confirm pluripotency. Although
locally organised tissues are able to form, the overall tissue architecture of teratomas
develop in a disorganised fashion due to uncoordinated developmental signals and a
failure to allow proper developmental morphogenetic processes to occur (Przyborski,
2005). In addition, care must be taken for considerations such as the site of cell im-
plantation and cell number implanted as both influence teratoma growth (Cooke et al.,
2006). One meta-analysis called into question the gold standard status of the teratoma
assay due to failure to report teratoma formation data in many newly derived hESC
and hiPSC lines—with half of hESC lines and over a third of hiPSC lines not including
any teratoma data in the primary literature reporting their derivation (Muller et al.,
2010).
With the increasing number of PSC lines being established it will be necessary to de-
velop new in vitro pluripotency testing methodologies that will reduce the need for in
vivo differentiation techniques such as the teratoma assay. Differentiation in vitro can
be more tightly controlled and studied than in vivo differentiation. In vitro differen-
tiation techniques offer alternative pluripotency tests and allow greater opportunities
for the generation of purified cell populations for cell transplantation and disease mod-
elling.
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1.3 In Vitro Differentiation
1.3.1 Differentiation in two-dimensions (2D)
The spontaneous differentiation of PSCs in 2D culture is disorganised and results in the
formation of a variety of somatic and extra-embryonic cell types, predominantly endo-
dermal lineages (Weitzer, 2006). Although purification of a desired cell type from com-
plex mixtures is possible, in order for the clinical applications of PSCs to be realised
directed differentiation to defined cell types is more desirable.
1.3.2 Directed differentiation
Taking a developmental biology approach to differentiation in vitro allows information
gained from studying embryonic development in model systems to be applied to the
directed differentiation of human PSCs for therapeutic purposes (Murry and Keller,
2008). Differentiation can be directed towards specific lineages by exogenous manip-
ulation of pathways that are active and required during embryonic fate specification.
Pathways such as Wnt/β -catenin, bone morphogenetic protein (BMP), FGF, sonic
hedgehog (Shh), and nodal/activin are associated with patterning the early embryo and
are frequently manipulated in vitro by using small molecules or recombinant proteins
to achieve desired differentiation outcomes (Murry and Keller, 2008).
A developmental biology approach to directed differentiation has been successful in
yielding pure populations of many somatic lineages from PSCs that may be useful for
therapeutic cell transplantation. For example, Najm et al. described an elegant process
that involved first specifying neuroepithelium (by inhibition of BMP and nodal/activin
signalling) followed by exposure to retinoic acid and Shh at levels that are present in
the ventral ventricular zone in the neural tube: the seat of oligodendrocytogenesis in
vivo (Najm et al., 2011). Oligodendrocyte progenitor cells (OPCs) that are widely ac-
cepted as having potential to treat demyelinating diseases such as multiple sclerosis
were robustly generated from EpiSCs with high efficiency and within a short space of
time.
hiPSCs are the most desirable PSC type for directed differentiation to somatic lineages
by minimising rejection risk (allowing autograft cell transplants) and facilitating the
study of disease mechanisms. OPCs (Wang et al., 2013), cardiomyocytes (Myers et al.,
2013), pancreatic islet cells (Thatava et al., 2011), hepatocytes (Roelandt et al., 2013),
and dopaminergic neurons (Cai et al., 2010) have all been generated from hiPSCs in
vitro and each of these breakthroughs may lead to regenerative medicine strategies for
currently incurable human diseases.
However, not all somatic lineages can be generated. Haematopoietic stem cells (HSCs)
can only be generated using inefficient EB cultures or teratomas (Chen, 2014; Amabile
et al., 2013), but could offer a significant source for autologous transplantation to treat
haematological diseases if an efficient and reproducible in vitro protocol existed. Study-
ing human embryonic development in vitro through the use of hiPSCs/hESCs may lead
to advances in directed differentiation that could result in improvements in generating
certain cell types with clinical applications such as HSCs.
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1.4 Developmental pathways
Development is a fascinating and tightly regulated process that requires coordinated
signals to generate functioning tissues and eventually whole organisms from tiny groups
of cells. Many signalling pathways have been studied with regards to their role in de-
velopment; some of which will be discussed with relevance to in vitro stem cell differen-
tiation.
1.4.1 Retinoic Acid Pathway
The vitamin A (retinol) derivative retinoic acid (RA) is essential for proper vertebrate
development (Rhinn and Dolle, 2012). RA exhibits pleiotropic effects and is implicated
in the development of the branchial apparatus, lung, pancreas, limbs, and somites,
and in hindbrain and forebrain patterning, and neural tube differentiation (Rhinn and
Dolle, 2012). Retinoids exhibit gene regulatory effects through binding to nuclear re-
ceptors (RARs/RXRs) to act as transcriptional activators of target retinoid-responsive
genes (Mark et al., 2009). RA morphogen gradients are tightly regulated during devel-
opment through the activities of synthesising and metabolising enzymes, and develop-
mental abnormalities occur if these enzymes are non-functional (Mic et al., 2004). RA
also acts as a teratogen at high concentrations when administered to embryos exoge-
nously (Durston et al., 1989). The role of RA in development has been studied exten-
sively in vivo and one isomer, all-trans-RA (ATRA), is also commonly used as an in
vitro inducer of stem cell differentiation.
ATRA was first shown to induce differentiation in murine EC cultures, producing neu-
ral and glial cell types (Jones-Villeneuve et al., 1982). ATRA treatment of mESCs
grown as EBs in suspension in vitro has been shown to direct differentiation to both
neural and endodermal lineages, indicating the diverse roles of ATRA in regulating de-
velopment (Bibel et al., 2004; Micallef et al., 2005). One of the limitations in study-
ing the role of ATRA in cell specification is its instability and propensity to isomersise
to any one of several different biologically active retinoids (that may have subtly dis-
tinct effects) upon heat or light exposure (Christie et al., 2010). This instability makes
the active concentration of ATRA difficult to tightly regulate, which is of critical im-
portance for accurately directing stem cell fate in vitro and generating reproducible
differentiation protocols. One solution is to use the synthetic retinoid ec23 that was de-
signed to be highly stable and to mimic ATRA activity (Christie et al., 2008). ATRA
and ec23 have both been shown to induce robust neural differentiation in hEC line
TERA2.cl.SP12 and induce formation of motor neurons in H9 hESCs (Christie et al.,
2010).
1.4.2 Bone morphogenetic protein pathway
Bone morphogenetic proteins (BMPs) are a related group of signalling molecules that
are members of the transforming growth factor β (TGF-β) superfamily. BMPs are lig-
ands that bind to serine/threonine kinase membrane receptors including type I (BMPR-
1A/ALK3, BMPR-1B/ALK6, ActR-1A/ALK2) and type II receptors (BMPR-2, ActR-
2A, ActR-2B) (Wang et al., 2014). Type II receptors transphosphorylate type I recep-
tors that phosphorylate and activate receptor regulated-Smads (R-Smads 1/5/8). R-
Smads form a complex with co-mediator Smad4 and this complex translocates to the
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nucleus where it exhibits gene regulatory effects through coactivators and corepressors
(Wang et al., 2013).
BMPs were first identified as potent inducers of ectopic bone growth but have wide
ranging roles in adult tissue homeostasis as well as being critical embryonic morphogens
(Urist and Strates, 1971; Li and Chen, 2013). The default model of neural plate spec-
ification postulates that neurogenesis is under inhibitory control: that BMP inhibitors
secreted by the organiser induce neural development in the embryonic ectoderm by in-
hibiting endogenous BMP activity that would result in epidermis formation (Spemann
and Mangold, 1924; Ozair et al., 2013).
BMP4 was the first BMP identified that was capable of blocking neural induction in
mammalian embryos (Wilson and Hemmati-Brivanlou, 1995). More recently, BMPs
have been used to promote the development of endoderm and mesoderm in ESC cul-
tures while inhibiting neurectodermal differentiation (Finley et al., 1999). BMP inhi-
bition is frequently used to induce neural differentiation in vitro from ESCs including
the small molecule dorsomorphin or the protein noggin (Groppe et al., 2002; Yu et al.,
2008; Najm et al., 2011). However, other pathways likely play a role in neural specifica-
tion and the absolute requirement for BMP inhibition has been challenged (Linker and
Stern, 2004).
1.4.3 Wnt/β-catenin pathway
The Wnt signalling cascade is a ubiquitous cell signalling pathway with diverse roles in
development and in the functioning of adult organisms (Arkell et al., 2013). β-catenin
plays a central role in the canonical Wnt pathway.
In the absence of Wnt ligand a destruction complex comprising of Axin, adenomato-
sis polyposis coli (APC), protein phosphatase 2A (PP2A), glycogen synthase kinase
3β (GSK3β) and casein kinase 1α (CK1α) phosphorylates cytoplasmic β-catenin and
it is subsequently ubiquitnylated and degraded by the proteasome (MacDonald et al.,
2009). Nuclear T cell factor/lymphoid enhancer factor (TCF/LEF) transcription fac-
tors inhibit the expression of Wnt target genes. Wnt ligand binding to Frizzled-family
receptors and low-density lipoprotein receptor related protein 5/6 (LRP5/6) corecep-
tors at the responding cell surface disrupts the destruction complex, allowing β-catenin
to translocate to the nucleus where it forms complexes with TCF/LEF factors and ac-
tivate Wnt target genes (MacDonald et al., 2009).
In the embryo, Wnt signalling is essential for primitive streak formation and mainte-
nance and favours mesdodermal differentiation at the expense of ectoderm (Gadue
et al., 2006; Murry and Keller, 2008; Arkell et al., 2013). Wnt3 signals along with ac-
tivin/nodal signalling specify the primitive streak population and in turn the anterior-
posterior embryonic axis that generates different mesodermal derivatives (Funa et al.,
2015).
Chiron99021 is a small molecule GSK3β inhibitor that is commonly used as an activa-
tor of Wnt signalling in vitro. Chi has been used to demonstrate that β-catenin induces
expression of primitive streak genes and primitive streak-like motile behaviours through
collaborative interactions with Oct4 and brachyury, respectively, in ESC in vitro mod-
els of primitive streak formation (Funa et al., 2015; Turner et al., 2014). Chi has also
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been used to generate gastruloids—mEBs that undergo gastrulation-like morphogenetic
proceses in response to Chi and activin A (van den Brink et al., 2014).
1.5 Differentiation in Three-Dimensions (3D)
Differentiation in 2D culture allows development potential to be examined in vitro
without the use of animals. However, in terms of pluripotency testing it would be time
consuming and costly to follow multiple directed differentiation protocols. Moreover,
the limitations of 2D culture methods are slowly becoming more widely accepted, in-
dicating the use of 3D cultures (Knight and Przyborski, 2014). For example; cell and
nuclear flattening, cytoskeletal changes, and changes in gene expression and protein
synthesis have all been reported in 2D culture (Vergani et al., 2004, Thomas et al.,
2002). Fundamentally, 2D culture represents an artificial environment for cell growth
and therefore the recapitulation of normal developmental processes in 2D cultures is
limited.
1.5.1 Aggregate Cultures
Early research identified the ability of mESCs to spontaneously aggregate in suspen-
sion and form aggregates termed embryoid bodies (EBs). Myriad methodologies have
since been developed for generating EBs from PSCs including liquid suspension culture,
stirred flask culture, rotary cell culture systems, hanging drop cultures, ultra-low adhe-
sion U-bottom multiwell plates, and indented solid microsurfaces (Aggrewell) (Sheri-
dan et al., 2012).
Aggregate cultures allow cells to produce their own extracellular matrix and provide
enhanced cell interactions compared to 2D culture (Knight and Przyborski, 2014). Ag-
gregation cultures of TERA2.cl.SP12 cells have been shown to substantially increase
the efficiency of neural induction in response to retinoic acid compared to 2D cultures,
higlighting the ability of this 3D culture technique to improve differentiation outomes
(Horrocks et al., 2003). Tisses representative of all three embryonic germ layers in-
cluding neuroepithelium, epidermis (ectoderm), connective tissues (mesoderm), and in-
testinal/respiratory epithelium (endoderm) spontaneously develop in EBs concomitant
with tissue-specific marker expression (Sheridan et al., 2012). EBs derived from ESCs
as well as iPSCs of murine or human origins undergo differentiation to all three germ
layers (Doetschman et al., 1985; Itskovitz-Eldor et al., 2000; Takahashi and Yamanaka,
2006; Takahashi et al., 2007).
For this reason EB formation has been used as an in vitro pluripotency assay that is an
animal-free alternative to teratoma formation (Sheridan et al., 2012). Moreover, human
EBs facilitate the study of early human embryonic development that is inaccessible in
vitro and may lead to advances in the clinical applications of PSCs. Marker expression
and local small-scale tissue morphology that is frequently observed in EBs, however,
does not mean that a functioning, in vivo-like tissue has been produced. Teratoma for-
mation produces more highly complex tissues than in EBs meaning that in vivo differ-
entiation techniques represent a more stringent test of developmental capacity (Buta
et al., 2013).
EB development has been shown to be equivalent to early embryonic development up
to 7 - 8 days (Weitzer, 2006) and more recent findings indicate their ability to undergo
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gastrulation-like processes in vitro (ten Berge et al., 2008; van den Brink et al., 2014).
Despite the resemblance of EB development to early embryogenesis, the later stages of
development are not accurately recapitulated in EBs (Weitzer, 2006). Over prolonged
periods in suspension culture differentiation in EBs is often disordered with abnormal
structures and cystic EBs frequently observed (Amit and Itskovitz-Eldor, 2002; Murry
and Keller, 2008). Ultimately, diffusion limits the ability of oxygen to reach the centre
of cell aggregates since they are avascular structures (Buta et al., 2013). A recent study
found that the oxygen concentration at the centre of large EBs (400 µm radius) was
50% lower than at the center of small EBs (200 µm radius) (Van Winkle et al., 2012).
While differences in oxygen concentrations may be useful for developing cellular diver-
sity within EBs, reduced nutrient availability can lead to the development of a hypoxic
core and cell death (Van Winkle et al., 2012; Knight and Przyborski, 2014).
Attachment is frequently used in the culture and differentiation of EBs and can provide
a more accurate recapitulation of the in utero environment through mimicking endome-
trial implantation (Weitzer, 2006). Moreover, EB flattening provides an enhanced abil-
ity of cells to recieve nutritional support via diffusion. However, EBs have traditionally
been attached to collagen or gelatin-coated 2D surfaces and under these conditions cells
migrate radially away from EBs (Evans et al., 1981; Takahashi and Yamanaka, 2006).
Attachment to a 2D substrate only provides nutritional support above the EB and cells
that are migrating away from EBs will grow in an artificial 2D environment.
3D culturing techniques such as aggregate cultures are becoming utilised more widely
due to the benefits that they provide over conventional 2D techniques (Knight and
Przyborski, 2014). An alternative 3D culture strategy to aggregation is the use of 3D
scaffolds.
1.5.2 Scaffold Technologies
Scaffolds have been utilised widely for 3D culturing because they provide enhanced cell
attachments in a 3D microenvironment that improves cell shape and better reflects the
in vivo situation compared to 2D substrates (Knight and Przyborski, 2014). 3D scaf-
folds can be made from different biological and synthetic materials using a variety of
techniques which have recently been reviewed by Knight and Przyborski (2014).
Biodegradable scaffolds can be made from an array of naturally occurring materials
including collagen (Baharvand et al., 2006), fibrin (Willerth et al., 2006), hyaluronic
acid (Gerecht et al., 2007), silk (Mauney et al., 2007), gelatin (Awad et al., 2004), al-
ginate (Li et al., 2010), and chitosan (Duarte et al., 2009), or synthetic materials such
as poly(l-lactic acid)(PLLA) and poly(lactic-co-glycolic acid)(PLGA)(Levenberg et al.,
2003) that may be used alone or blended. Scaffolds have been used frequently to sup-
port differentiation of ESCs in a 3D environment.
For example, PLLA/PLGA synthetic scaffolds have been used to support hESC differ-
entiation and shown to facilitate the development of neural, cartilage, and liver tissues
(Levenberg et al., 2003). One of the benefits of biobiodegradable scaffolds is that they
degrade making them highly suitable for tissue engineering applications where cells can
penetrate and remodel the scaffold. However, this instability may be a hindrance for
routine cell culture applications where degradation may be difficult to control and have
undesirable effects on cell differentiation (Knight et al., 2011).
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Hydrogels have a high water content and can be formed from collagen-1, matrigel,
gelatin, and hyaluronic acid and have been used to support differentiation in murine
EBs (mEBs) (Kothapalli and Kamm, 2013). mEBs were embedded in hydrogels that
provided a 3D structure to support their growth and maintenance facilitating differ-
entiation to neural and glial lineages in response to ATRA and Shh (Kothapalli and
Kamm, 2013). One of the limitations of the use of hydrogels is that they can impact
differentiation outcomes in unpredictable ways. Collagen-1 hydrogels, for example, pro-
moted motor neuron differentiation, while matrigel stimulated development of dopamin-
ergic neurons (Kothapalli and Kamm, 2013). Furthermore, hydrogels may not provide
sufficient transfer of nutrients to support long-term differentiation (Jongpaiboonkit
et al., 2008).
For routine cell culture, chemically inert scaffolds may be preferred because they pro-
vide reproducibility that is not easy to achieve with biodegradable scaffolds or hydro-
gels (Bokhari et al., 2007).
1.5.3 Alvetex®polystyrene scaffolds
Alvetex®is a rigid polystyrene 3D scaffold generated by polymerisation in high inter-
nal phase emulsion (polyHIPE) that is biocompatible, non-biodegradable, and highly
porous (Knight et al., 2011). Alvetex®is available in a well-insert format containing a
scaffold membrane of 200 µm thick. The size of the pores and interconnects within the
scaffold can be tightly regulated according to polymerisation conditions (Knight et al.,
2011).
A novel approach is to combine two common 3D culture strategies and to maintain
stem cell aggregates on top of 3D inert synthetic scaffolds. Alvetex®has been shown
to support differentiation in 3D stem cell aggregates and supported enhanced neu-
ral differentiation in TERA2.cl.SP12 aggregates (Hayman et al., 2004). Combining
3D culture techniques in this way has been shown to result in the formation of flat-
tened tissue-discs from spheroid stem cell aggregates that may provide a mechanism
to extend the culture time of EBs in vitro by improving nutritional support for cells
throughout the entire aggregate via diffusion (E. Knight, PhD thesis). Moreover, phys-
ical attachment is a normal process during development in utero and could improve
the recapitulation of the latter stages of embryonic development compared to aggregate
suspension cultures.
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Figure 4: Images of Alvetex®porous polystyrene scaffold 6-well inserts.
Alvetex®porous polystyrene scaffolds are available as 6-well cell culture inserts (A)
and consist of a porous polystyrene membrane with interconnects and voids whose
size can be tightly regulated. Scanning electron micrograph (B) shows the detailed
structure of Alvetex®Polaris with an average pore size of 3-4 µm. (A) was taken from
www.reinnervate.com and (B) was kindly provided by R. Quelch, Durham University.
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1.6 Aim and Objectives
The aim of this thesis is to investigate the maintenance of hEC aggregates and mEBs
using Alvetex®3D scaffolds. Four main objectives will be explored: (1) is complex
tissue development supported in tissue-discs? (2) is cell viability improved due to in-
creased nutritional support over prolonged in vitro cultures? (3) can tissue-disc cul-
tures be used to study aspects of human embryonic development? and (4) could this
technique be adopted as a novel in vitro pluripotency assay?
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2 Materials and Methods
2.1 2D Cell Culture
2.1.1 Human Embryonal Carcinoma Line TERA2.cl.SP12
The human embryonal carcinoma line TERA2.cl.SP12 was cultured according to es-
tablished protocols (Przyborski, 2001). Cells were maintained using high glucose Dul-
becco’s Modified Eagle Medium (Lonza) supplemented with 10% heat-inactivated fetal
calf serum (Gibco, Invitrogen), 2 mM L-glutamine (Lonza), and 1 ml penicillin/streptomycin
(Lonza).
Frozen stocks were resuscitated by thawing cryovials as quickly as possible in a water
bath at 37oC and adding to 9 ml prewarmed media in a 15 ml Falcon tube (Starstedt).
Cells were centrifuged at 1000 rpm for 3 minutes and supernatant removed. The cell
pellet was resuspended in 10 ml prewarmed media and seeded into one T25 flask (BD
Bioscience). Flasks were incubated in a humidified atmosphere with 5% CO2 at 37
oC
and the media was changed every 1 - 2 days. Once confluent (after about 3 days), cells
were passaged by rolling sterile, acid-washed glass beads over the culture and splitting
them into one fresh T75 flask, and thereafter split 1:3 into fresh T75 flasks.
In order to obtain specific cell numbers, cultures were washed in 5 ml Dulbecco’s phos-
phate buffered saline (D-PBS, Lonza) and incubated with 3 ml trypsin/EDTA solu-
tion (Lonza) at 37oC for 3 minutes to obtain a single cell suspension. Trypan blue stain
(Sigma) was used to identify viable cells and a Neubauer improved haemocytometer
was used to calculate cell numbers. Cells were frozen down at approximately 1x107
cells per ml in 90% heat-inactivated fetal calf serum and 10% DMSO (Sigma) in 1 ml
cryovials (Nunc). Cells were stored at −80oC using Nalgene’s Mr Frosty for 24 hours
before being transferred for long-term storage at −150oC.
2.1.2 Mouse Embryonic Stem Cell Line CGR8
Mouse embryonic stem cell line CGR8 was obtained from Public Health England at
passage 5. For routine culture, mESCs were grown using maintenance medium that
consisted of Glasgow Minimum Essential Medium (GMEM, Sigma) supplemented with
10% pluripotent stem cell-qualified fetal calf serum (amsbio), 2 mM L-glutamine (Lonza),
0.05 mM 2-Mercaptoethanol (Sigma), and 1000 U/ml leukaemia inhibitory factor (LIF,
amsbio).
Frozen stocks were resuscitated by thawing cryovials as quickly as possible in a wa-
ter bath at 37oC and adding to 5 ml prewarmed maintenance medium in a 15 ml Fal-
con tube. Cells were centrifuged at 1000 rpm for 3 minutes and supernatant removed.
The cell pellet was resuspended in 10 ml prewarmed maintenance medium and seeded
into one 0.2% gelatin coated T25 flask (Nunc). Cells were grown in 0.2% gelatin coated
T25 flasks and incubated in a humidified atmosphere with 5% CO2 at 37
oC. Media was
changed daily and cultures were split 1:10 when they reached 70% confluency.
When splitting cells it was necessary to seed cells as a single cell suspension. Cultures
were washed in D-PBS before incubating with 1 ml trypsin/EDTA solution at 37oC
for 3 minutes, and then pipetting up and down several times vigorously. Trypsin was
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inactivated by adding 9 ml maintenance media which was then transferred to a fresh
gelatin-coated T25 flask.
0.2 % gelatin solution was prepared by adding 0.2 g gelatin powder (Sigma) to 100 ml
D-PBS before being autoclaved at 120oC for 20 minutes in order to dissolve the gelatin.
4 ml 0.2 % gelatin solution was added to T25 flasks that were incubated for at least
4 hours at 37oC before use. Flasks were stored for up to 1 week at 37oC and gelatin
solution was aspirated just prior to seeding the cells.
2.2 Aggregate Formation
2.2.1 TERA2.cl.SP12 Aggregates
In order to generate aggregates of TERA2.cl.SP12 human embryonal carcinoma cells,
a spontaneous aggregation technique was used. 1 ml media containing 1.5x106 single
cells in suspension were seeded into non-tissue culture treated 10 cm plates (Fisher)
and topped up with media to 20 ml. Plates were incubated in a humidified atmosphere
with 5% CO2 at 37
oC for 24 h to allow aggregates to form before inducers were added
directly to the media which was gently swirled in order to evenly distribute the in-
ducer.
Aggregate media was changed every 3.5 days by collecting aggregates in suspension
into a 50 ml Falcon tube (Starstedt) and allowing them to sediment over 2-5 minutes
before aspirating spent medium and replacing with 20 ml fresh medium. Aggregates
were resuspended by gently swirling the Falcon tube before pouring the suspension into
a fresh 10 cm plate, adding inducers directly to the medium and gently swirling it to
evenly distribute the inducers. Aggregates were maintained in suspension for up to 21
days.
2.2.2 CGR8 Murine Embryoid Bodies
AggreWell800 plates (Stem Cell inc.) were used to obtain uniform aggregates /embry-
oid bodies (mEBs) of CGR8 mouse embryonic stem cells. For formation and mainte-
nance of mEBs, mEB media was used consisting of mESC maintenance media without
the addition of LIF and with the addition of either 10% or 20% heat inactivated FBS
(Gibco, invitrogen).
Each well of the AggreWell800 plate to be used for mEB formation was first rinsed
with 2 ml prewarmed mEB medium that was then aspirated. 0.5 ml prewarmed mEB
medium was added to the rinsed wells and the plate was centrifuged at 2000 g for 5
minutes. It was essential to balance the centrifuge correctly using another AggreWell800
plate. An inverted phase-contrast microscope was used to check that all air bubbles in-
side the wells were properly displaced.
mEB formation required seeding accurate cell numbers. A single cell suspension was
achieved by washing cells in D-PBS before incubating with 3 ml trypsin/EDTA solu-
tion at 37oC for 3 minutes and then pipetting up and down several times vigorously.
Trypsin was inactivated by adding 10 ml prewarmed mEB medium and the single cell
suspension was centrifuged at 1000 rpm for 3 minutes. The cell pellet was resuspended
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in 10 ml prewarmed mEB medium and trypan blue stain was used to identify viable
cells and a haemocytometer was used to calculate cell numbers.
3x105 cells were added to 0.5 ml mEB medium in each well of the AggreWell800 plate
to be used and pippetted up and down several times to evenly distribute the cells.
Each well containing 3x105 cells generated 300 mEBs consisting of 1000 cells per mEB.
Total medium in each well was adjusted to 2 ml and the plate was centrifuged at 100 g
for 3 minutes.
The AggreWell800 plate was incubated in a humidified atmosphere with 5% CO2 at
37oC for 72 hours with careful 1 ml media changes every 24 hours in order not to dis-
turb the mEBs. mEBs were harvested after 72 hours by pipetting up and down with
moderate force 2-3 times to ensure that all mEBs had left their microwells. mEBs in
suspension were strained through a 37 µm cell strainer (VWR). Each well was washed
with 2 ml mEB medium and strained again. The well was visualised using an inverted
phase-contrast microscope to ensure all mEBs had been removed.
mEBs were washed into non-tissue culture treated 10 cm plates at 300 mEBs per plate
with 20 ml prewarmed mEB medium. Plates were incubated in a humidified atmo-
sphere with 5% CO2 at 37
oC for 5 days and were physically agitated 3 times per day
during the first 2 days of culture to try to prevent mEBs adhering to each other.
2.3 Small Molecules and Recombinant Proteins
Small molecules and recombinant proteins that were used as inducers of stem cell dif-
ferentiation were added directly to the media of aggregates cultured in suspension. The
concentrations at which inducers were used for differentiation and the suppliers from
which they were acquired are shown in the table below.
Table 1: Small molecules and recombinant proteins used as inducers of stem cell dif-
ferentiation.
Inducer Concentration Supplier
ec23 0.01 µM ReproCELL Reinnervate
BMP-2 50 ngml−1 amsbio
Noggin 100 ngml−1 amsbio
Dorsomorphin 1 µM Sigma
Chir99021 3 µM Sigma
2.4 Alvetex® 3D Aggregate Cultures
Alvetex®3D polystyrene scaffold membranes (ReproCell Reinnervate) were prepared
using an EMITECH K1050X plasma treater set to 40 W power and 5 minutes ashing
time in order to render the polystyrene surfaces hydrophylic. Alvetex® 3D polystyrene
scaffolds may also be prepared by dipping the membrane in 70 % ethanol followed by
two washes in sterile PBS. Alvetex® 6-well inserts were placed into a 6-well culture
plate (Greiner Bio-one) and hydrated by adding 8 ml of the appropriate culture media.
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Aggregates in suspension were collected and passed through a 100 µm cell strainer
(VWR) in order to remove any single cells before being washed back into a fresh 10 cm
plate with 10 ml of prewarmed culture media. 1-2 aggregates were collected in a 1000
µl pipette tip (cut to an appropriate size for larger aggregates) and ejected on top of
the Alvetex® membrane. This was repeated 2-3 times per 6-well insert in order to seed
2-6 aggregates per membrane, ensuring that aggregates were not in close proximity to
each other. 3D aggregate cultures were incubated in a humidified atmosphere with 5%
CO2 at 37
oC for up to 32 days with 50% media changes every 3 - 4 days.
2.5 Histology
2.5.1 Paraffin Embedding of Aggregate Suspension Cultures
Aggregates in suspension were collected and passed through a 100 µm filter in order to
remove any single cells before being washed back into a 15 ml falcon tube and washed
three times in D-PBS, allowing aggregates to settle to the bottom of the tube between
each step. Aggregates were fixed at room temperature in 4% paraformaldehyde for 30
minutes and then washed three times in D-PBS. Samples were stored in D-PBS in 15
ml Falcon tubes at 4oC until ready for further processing.
D-PBS was removed and samples dehydrated at room temperature through 30% ethanol
and then 50% ethanol for 10 minutes each, allowing aggregates to settle between each
step. Aggregates were stained with 2 ml 0.05% crystal violet in 70% ethanol for 10
minutes in order to aid sectioning. Samples were then dehydrated through 80%, 90%
90% and 100% ethanol for 10 minutes each, being careful to ensure aggregates remained
at the bottom of the Falcon tube.
100% ethanol was removed and aggregates resuspended in 2-3 ml Histoclear for 10 min-
utes at room temperature. The same amount of liquid wax at 60oC was added to the
Falcon tubes to achieve 50:50 wax:histoclear and incubated for 30 minutes at 60oC.
50:50 wax:histoclear was aspirated using a prewarmed Pasteur pippette and replaced
with 2-3 ml of liquid wax at 60oC and incubated for 30 minutes. Liquid wax was re-
placed for a second 30 minute incubation at 60oC.
Samples were set into wax blocks using dispomoulds (Cell path) and allowed to set
overnight before sectioning at 6 µm using a Leica RM2125RT microtome and mounted
onto Superfrost microscope slides (Fisher).
2.5.2 Paraffin Embedding of Alvetex® 3D Aggregate Cultures
Alvetex® 3D polystyrene scaffold membranes were unclipped from their inserts and
placed into 2-3 ml D-PBS in fresh 6-well culture plates. D-PBS was aspirated and mem-
branes were washed again in 2-3 ml D-PBS. D-PBS was replaced with 2-3 ml 4% paraformalde-
hyde and samples were fixed overnight for 16 hours at 4oC. Fixative was removed and
replaced with 2-3 ml D-PBS and this was repeated for a total of three PBS washes.
Samples were stored at 4oC in D-PBS until ready for further processing.
D-PBS was removed and samples dehydrated at 4oC with 2-3 ml 30% ethanol and then
50% ethanol for 30 minutes each. Aggregates were stained with 2-3 ml 0.05% crystal
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violet in 70% ethanol for 10 minutes at 4oC in order to aid sectioning. Samples were
then dehydrated through 80%, 90%, 95% and 100% ethanol for 10 minutes each at 4oC.
Alvetex® inserts were removed from 100 % ethanol, cut in half and transferred into
glass vials containing 15 ml Histoclear and incubated for 15 minutes at room temper-
ature. The same amount of liquid wax at 60oC was added to the glass vials to achieve
50:50 wax:histoclear and incubated for 30 minutes at 60oC. 50:50 wax:histoclear was
poured away and replaced with 30 ml of liquid wax at 60oC and incubated for 60 min-
utes.
Samples were set into wax blocks using dispomoulds and allowed to set overnight be-
fore sectioning at 8 µm using a Leica RM2125RT microtome and mounted onto Super-
frost microscope slides.
2.5.3 Haematoxylin and Eosin Staining
Slides were deparaffinised in Histoclear for 5 minutes before being rehydrated in 100%
ethanol for 2 minutes, 95% ethanol for 1 minute, 70% ethanol for 1 minute and deionised
water for 1 minute. Slides were stained in Mayer’s Haematoxylin for 5 minutes, then
rinsed for 30 seconds in deionised water and nuclei were blued in alkaline ethanol for
30 seconds. Slides were dehydrated through 70% ethanol for 1 minute and then 95%
ethanol for 1 minute before staining in 0.002% eosin dissolved in 95% ethanol for 1
minute. Slides were rinsed in 95% ethanol for 10 seconds, followed by another rinse
in 95% ethanol for 15 seconds and then dehydrated through 100% ethanol for 15 sec-
onds and then 100% ethanol for 30 seconds. Slides were cleared using two incubations
in Histoclear for 3 minutes each. Slides were stored in Histoclear before being mounted
using DPX (Fisher) and glass coverslips (Fisher). Bright-field images were taken using
a Leica ICC50HD microscope.
2.5.4 Masson’s Trichrome Staining
Slides were deparaffinised in Histoclear for 5 minutes before being rehydrated in 100%
ethanol for 2 minutes, 95% ethanol for 1 minute, 70% ethanol for 1 minute and deionised
water for 1 minute. Slides were stained in Weigert’s iron Haematoxylin for 10 minutes
and then rinsed under running tap water for 10 minutes before being briefly rinsed in
deionised water. Slides were stained using Biebrich scarlet for 15 minutes and then
rinsed in distilled water. Slides were differentiated in phosphomolybdic/phosphotungstic
acid for 15 minutes and then transferred directly to aniline blue stain for 7 minutes.
Slides were rinsed in distilled water and then differentiated in 1% acetic acid for 3 min-
utes before being rinsed in distilled water. Slides were quickly dehyrdated through
100% ethanol and 95% ethanol for 10 seconds each to avoid losing Biebrich scarlet
stain. Slides were cleared using two incubations in Histoclear for 3 minutes each. Slides
were stored in Histoclear before being mounted using DPX and glass coverslips. Bright-
field images were taken using a Leica ICC50HD microscope.
2.5.5 Alizarin Red Staining
Alizarin Red solution was prepared by dissolving Alizarin Red S powder (Sigma) in 100
ml deionised water and adjusting the pH to 4.1 -4.3 with 10% ammonium hydroxide.
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Slides were deparaffinised in Histoclear for 5 minutes before being rehydrated in 100%
ethanol for 2 minutes, 95% ethanol for 1 minute, 70% ethanol for 1 minute and deionised
water for 1 minute. Slides were stained in Alizarin Red solution for 2 minutes and ex-
cess dye was shaken off before blotting slides dry. Sections were dehydrated by dip-
ping in acetone for 20 dips, followed by dipping in 50:50 acetone:Histoclear for 20 dips.
Slides were cleared using two incubations in Histoclear for 3 minutes each. Slides were
stored in Histoclear before being mounted using DPX and glass coverslips. Bright-field
images were taken using a Leica ICC50HD microscope.
2.5.6 Immunohistochemistry
Slides were deparaffinised in Histoclear for 10 minutes before being rehydrated in 100%
ethanol for 2 minutes, 95% ethanol for 1 minute, 70% ethanol for 1 minute and deionised
water for 1 minute. Heat-mediated antigen retrieval was carried out on slides submerged
in citrate buffer (pH 6.0) that were microwaved for 2 minutes on full power followed by
1 minute rest with the microwave door open. This step was repeated twice for a total
of 3 x 2 minutes microwave heating. Slides submerged in citrate buffer were allowed to
cool for 20 minutes at room temperature. Slides were incubated for 1 hour on a rocker
at 50 rpm in block/permeabilisation buffer containing 0.4% triton X-100 (Fisher) and
20% normal goat serum (Sigma) in PBS. A hydrophobic pen (Liquid blocker) was used
to draw around samples on slides. Samples were incubated overnight at 4oC with 50-
200 µl of primary antibody diluted to an appropriate concentration in block/permeabilisation
buffer.
Slides were washed three times in 300 µl PBS for 10 minutes each on a rocker at 50
rpm. Appropriate fluorescently-labelled secondary antibodies were diluted 1:1000 with
1:1000 Hoechst 33342 (Molecular probes) in PBS containing 0.1% Tween-20 (Sigma)
and incubation was carried out for 1 hour in the dark at room temperature. Slides were
washed three times in 300 µl PBS for 10 minutes each on a rocker at 50 rpm in the
dark. Slides were mounted with a small amount of VECTASHIELD®antifade mount-
ing medium (Vector laboratories) and a glass coverslip. Coverslips were sealed with a
generous amount of nail varnish and allowed to set at room temperature for 1-2 hours
before storing slides in the dark at 4oC. Slides were imaged within 1 week of staining
using one of the following epifluorescent microscopes (Leica DMI3000B, Zeiss Axiovert
40, Zeiss Axioskop 40), or one of the following laser-scanning confocal microscopes
(Zeiss 510 CLSM, Zeiss 880 CLSM, Leica SP5 CLSM).
Table 2: Primary and secondary antibodies used in immunohistochemistry.
Antibody Code Manufacturer Species and Isotype Dilution
TUJ1 PRB-435P Covance Rabbit polyclonal IgG 1:600
anti-E-cadherin ab76055 Abcam Mouse monoclonal IgG 1:250
anti-Nestin ab22035 Abcam Mouse monoclonal IgG 1:100
anti-CK8 ab9023 Abcam Mouse monoclonal IgG 1:250
anti-GATA4 ab84593 Abcam Rabbit polyclonal IgG 1:50
anti-α-SMA ab5694 Abcam Rabbit polyclonal IgG 1:100
anti-col-IV ab6586 Abcam Rabbit polyclonal IgG 1:500
anti-Rabbit IgG AlexaFluor 488 ab150077 Abcam Goat polyclonal IgG 1:1000
anti-Mouse IgG AlexaFluor 488 ab150113 Abcam Goat polyclonal IgG 1:1000
23
2.6 Flow Cytometry
TERA2.cl.SP12 cells were grown to 90% confluency in a T75 flask and a single cell sus-
pension was generated. Cultures were washed using 5 ml D-PBS and then incubated
with 3 ml trypsin/EDTA solution at 37oC for 3 minutes. Trypsin was inactivated us-
ing 7 ml prewarmed culture media and cells were pipetted up and down several times
before being placed into a 15 ml Falcon tube. Cells were centrifuged at 1000 rpm for
3 minutes and supernatant aspirated. The pellet was resuspended in PBS and cen-
trifuged again at 1000 rpm for 3 minutes. The PBS wash step was repeated for a total
of 2 washes. Cells were resuspended in 0.1% Bovine Serum Albumin (BSA, Sigma) in
PBS and cell numbers were counted using trypan blue viablity assay and a haemocy-
tometer.
2x105 cells in 0.1% BSA were added to each well to be used of a U-bottomed 96-well
plate (Greiner Bio-one). Three wells were used for each primary antibody with one
extra well for the isotype control antibody anti-P3X. Plates were centrifuged at 1000
rpm at 4oC for 3 minutes and supernatant removed by upturning the plate in one swift
motion. Pellets were resuspended using 50 µl of the appropriate primary antibody di-
luted in 0.1% BSA solution and incubated on ice for 60 minutes. 100 µl of 0.1% BSA
solution was added to each well to remove excess unbound antibody and the plate was
centrifuged at 1000 rpm at 4oC for 3 minutes. Supernatant was removed pellets were
resuspended in 180 µl of 0.1% BSA solution. Plates were centrifuged at 1000 rpm at
4oC for 3 minutes and the wash step was repeated for a total of 2 washes.
Plates were centrifuged at 1000 rpm and 4oC for 3 minutes and supernatant removed.
Cell pellets were resuspended in secondary antibody diluted to the appropriate concen-
tration in 0.1% BSA and incubated in the dark on ice for 60 minutes. 100 µl of 0.1%
BSA solution was added to each well to remove excess unbound antibody and the plate
was centrifuged at 1000 rpm and 4oC for 3 minutes. Supernatant was removed and pel-
lets resuspended in 180 µl 0.1% BSA solution. Plates were centrifuged at 1000 rpm and
4oC for 3 minutes and the previous wash step repeated for a total of 2 washes.
Plates were centrifuged at 1000 rpm and 4oC for 3 minutes and supernatant removed.
Pellets were resuspended in 200 µl 0.1% BSA for performing flow cytometry. Flow cy-
tometry was performed using Guava Technologies EasyCyte Plus flow cytometer ac-
cording to the manufacturer’s instructions.
Table 3: Primary and secondary antibodies used in flow cytometry.
Antibody Code Manufacturer Species and Isotype Dilution
anti-P3X n/a Tonge et al. (2010) Mouse monoclonal IgM 1:10
anti-SSEA-3 MC-631 DSHB Mouse monoclonal IgM 1:5
anti-TRA-1-60 MAB4360 Merck Millipore Mouse monoclonal IgM 1:50
anti-A2B5 MAB1416 R&D Systems Mouse monoclonal IgM 1:10
anti-Mouse IgM FITC F9259 Sigma-Aldrich Goat polyclonal IgG 1:100
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2.7 Immunocytochemistry
Cells grown in 6- or 12-well tissue culture plates were washed twice in PBS and then
fixed for 15 minutes at room temperature using 4% paraformaldehyde solution in PBS.
All subsequent steps were performed on ice and on a rocker at 50 rpm. Cells were per-
meabilised for 15 minutes using 0.01% Triton X-100 in PBS and then incubated in
blocking buffer for 30 minutes containing 10% normal goat serum and 0.01% Tween-20
in PBS. Primary antibodies diluted to the appropriate concentration in blocking buffer
were added to wells (200 µl per 12-well or 1 ml per 6-well) and incubated for 60 min-
utes. Cells were washed in 1 ml blocking buffer and this wash step was repeated twice
for a total of three washes. Wells were incubated with the same amount of appropri-
ate secondary antibody diluted in blocking buffer with 1:1000 Hoechst 33342 and plates
were incubated in the dark for 60 minutes. Wells were washed three times in blocking
buffer and then topped up with PBS and sealed with parafilm before imaging.
Table 4: Primary and secondary antibodies used in immunocytochemistry.
Antibody Code Manufacturer Species and Isotype Dilution
TUJ1 PRB-435P Covance Rabbit polyclonal IgG 1:600
anti-CK8 ab9023 Abcam Mouse monoclonal IgG 1:250
anti-SOX-2 ab97959 Abcam Rabbit polyclonal IgG 1:1000
anti-SSEA-1 ab16285 Abcam Mouse monoclonal IgM 1:100
anti-Oct4 ab19857 Abcam Rabbit polyclonal IgG 1:200
anti-Nanog ab80892 Abcam Rabbit polyclonal IgG 1:150
anti-Rabbit IgG Alexa Fluor 488 ab150077 Abcam Goat polyclonal IgG 1:600
anti-Mouse IgG Alexa Fluor 488 ab150113 Abcam Goat polyclonal IgG 1:600
anti-Mouse IgM FITC F9259 Sigma-Aldrich Goat polyclonal IgG 1:100
2.8 Terminal deoxynucleotidyl transferase dUTP nick end la-
beling (TUNEL)
DeadEndFluorometric TUNEL System (Promega) was used according to the manufac-
turer’s instructions.
Samples were deparaffinised with two incubations in Histoclear for 5 minutes each and
then washed in 100% ethanol for 5 minutes. Samples were rehydrated in 100%, 95%,
85%, 70%, and 50% ethanol for 3 minutes each. Samples were washed in 0.85% NaCl
for 5 minutes and then washed in PBS for 5 minutes. Tissue sections were fixed in 4%
paraformaldehyde in PBS for 15 minutes at room temperature, and then washed twice
in PBS for 5 minutes each. Liquid was removed and the slides were placed onto a flat
surface.
100 µl Proteinase K solution [20 µgml−1] was added to each slide to cover the sam-
ple and then incubated for 10 minutes at room temperature. Samples were washed in
PBS for 5 minutes, then fixed in 4% paraformaldehyde solution in PBS for 5 minutes
at room temperature, and then washed again in PBS for 5 minutes.
Excess liquid was removed and samples were then incubated with 100 µl equilibration
buffer for 5 minutes at room temperature. Samples were incubated in a humid chamber
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for 60 minutes at 37oC with 50 µl rTdT incubation buffer containing 5 µl nucleotide
mix and 1 µl rTdT enzyme in 45 µl equilibration buffer. Samples were prevented from
drying out by placing a small piece of parafilm on top of each slide. Slides were kept in
the dark after completion of this step.
Tailing reactions were terminated by immersing slides in 2X SSC buffer for 15 minutes
at room temperature. Samples were washed three times in PBS for 5 minutes each.
Slides were mounted onto glass coverslips using a small amount of VECTASHIELD®hardset
antifade mounting medium with DAPI (Vector Laboratories).
Slides were stored in the dark at 4oC and imaging of samples was performed the follow-
ing day using a Zeiss 510 CLSM.
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3 Results
3.1 Human Embryonal Carcinoma Cell Line TERA2.cl.SP12
2D cultures of TERA2.cl.SP12 hEC cells were maintained according to pre-established
protocols (Przyborski, 2001). Flow cytometric analysis of surface antigen expression
was performed in order to characterise hEC cells maintained at high confluency in
2D. Flow cytometry revealed that the glycolipid surface antigens SSEA-3 and TRA-
1-60 that are associated with pluripotency in hESCs were expressed on the majority of
TERA2.cl.SP12 cells (90.1% and 98.1% respectively) (Figure 5) (Mart´ı et al., 2013).
The early neural lineage marker A2B5 was not found to be expressed in TERA2.cl.SP12
cells and showed similar expression levels to the isotype control antibody P3x (Chua
et al., 2009). Flow cytometric analysis therefore indicated that TERA2.cl.SP12 cells
cultured at high confluency in 2D were maintained as undifferentiated stem cells with
no evidence of spontaneous neural differentiation.
Immunocytochemistry was undertaken in order to characterise TERA2.cl.SP12 cells
cultured at different cell densities in 2D. Cells were seeded at high density (1.5x104
cells per cm2), medium density (1.0x104 cells per cm2), or low density (5x103 cells per
cm2) and cultured for 4 days and expression of pluripotency marker Oct4 and differen-
tiated cell markers TUJ1 and CK8 were analysed. TUJ1 antibodies react with β-III-
tubulin that is predominantly expressed in mature neurons of the central nervous sys-
tem but also testis and highly proliferative cancer cells (De Gendt et al., 2011; Katsetos
et al., 2003; Ferrandina et al., 2006). CK8 antibodies react with cytokeratin-8 interme-
diate filament protein that is commonly expressed in cultured epithelial cells and all
simple epithelial tissues (Magin et al., 1986).
Expression of Oct4 (Figure 6), TUJ1 (Figure 7), and CK8 (Figure 8) was detected
in TERA2.cl.SP12 cells cultured at high, medium, and low density. Only hEC cells cul-
tured at high and medium density exhibited characteristic pluripotent stem cell mor-
phology, however, including small size, rounded morphology, and high nucleus:cytoplasm
ratio. hEC cells cultured at low density were considerably larger and had a distinctly
lower nucleus:cytoplasm ratio. Moreover, CK8 and TUJ1 staining formed filamentous
structures within hEC cells cultured at low density, indicating that they had gained a
more differentiated phenotype compared to cells cultured at high density where diffuse
TUJ1 and CK8 staining was seen.
Taken together these data indicate that TERA2.cl.SP12 cells were maintained in an
undifferentiated state when cultured at high density in 2D culture. TERA2.cl.SP12
hEC cells were therefore chosen as a useful and an inexpensive research tool for op-
timisation of the technique for long-term maintenance of stem cell aggregates using
Alvetex® 3D scaffold membranes.
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Figure 5: Flow cytometric analysis of TERA2.cl.SP12 cells cultured in 2D.
Surface antigens were detected using flow cytometry and dot plots of the data are pre-
sented with forward scatter (FSC) on the x-axis and FITC fluorescence detected for
each antibody on the y-axis. Pluripotency marker TRA-1-60 expression was detected
in 98.1% of cells and pluripotency marker SSEA-3 expression was detected in 90.1% of
cells. A2B5 expression was not detected on TERA2.cl.SP12 cells as FITC fluorescence
was at a similar level to the isotype control antibody anti-P3x.
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Figure 6: Oct4 expression in TERA2.cl.SP12 cells.
Immunocytochemical detection of Oct4 expression in TERA2.cl.SP12 cells seeded
at high density (1.5x104 cells per cm2), medium density (1.0x104 cells per cm2), and
low density (5x103 cells per cm2) and cultured for 4 days in 2D. Cells cultured at all
three densities showed detectable Oct4 expression. Cells cultured at high density were
smaller in size than cells cultured at medium or low density. All images were taken us-
ing a Zeiss Axiovert 200 inverted epifluorescent microscope with a 63x objective. Scale
bars represent 50 µm.
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Figure 7: TUJ1 expression in TERA2.cl.SP12 cells.
Immunocytochemical detection of TUJ1 expression in TERA2.cl.SP12 cells seeded
at high density (1.5x104 cells per cm2), medium density (1.0x104 cells per cm2), and
low density (5x103 cells per cm2) and cultured for 4 days in 2D. Cells cultured at high
and medium density exhibited diffuse TUJ1 staining compared to filamentous staining
seen in cells cultured at low density. All images were taken using a Zeiss Axiovert 200
inverted epifluorescent microscope with a 63x objective. Scale bars represent 50 µm.
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Figure 8: CK8 expression in TERA2.cl.SP12 cells.
Immunocytochemical detection of CK8 expression in TERA2.cl.SP12 cells seeded
at high density (1.5x104 cells per cm2), medium density (1.0x104 cells per cm2), and
low density (5x103 cells per cm2) and cultured for 4 days in 2D. Cells cultured at low
density exhibited filamentous CK8 staining compared to diffuse staining seen in cells
cultured at high and medium density. All images were taken using a Zeiss Axiovert 200
inverted epifluorescent microscope with a 63x objective. Scale bars represent 50 µm.
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3.2 TERA2.cl.SP12 Aggregates
TERA2.cl.SP12 hEC cells were cultured as a monolayer in 2D and aggregates were
formed by allowing spontaneous aggregation of hEC suspension cultures to occur. Ag-
gregates were maintained in suspension for 21 days and histological analysis was used
to investigate the internal structure of hEC cell aggregates. Epithelial cavities con-
taining polarised epithelial cells were visible in haematoxylin and eosin-stained paraffin
transverse sections (arrows, Figure 9). Epithelial structures resembled neural rosettes
that are typical of neuroepithelial development, suggesting that 3D culturing of TERA2.cl.SP12
cells as aggregates had induced spontaneous neural differentiation (Gotz and Huttner,
2005). Histological analysis also indicated that significant necrosis had occurred in
TERA2.cl.SP12 aggregates after 21 days in suspension—evident as a central region of
debris that contained small dark cell nuclei that were indicative of cell death (asterisks,
Figure 9).
3.2.1 Maintenance of TERA2.cl.SP12 Aggregates using 3D Scaffolds
At the same time as maintaining TERA2.cl.SP12 cells for 21 days in suspension, af-
ter 14 days in suspension some aggregates were cultured for 7 days using Alvetex® 3D
porous polystyrene scaffold membranes of three different pore sizes. TERA2.cl.SP12
aggregates cultured for 7 days using Alvetex® Scaffold (that has an average pore size
of 40 µm) largely disintegrated and cells penetrated the full depth of the scaffold, ap-
proximately 200 µm (Figure 10C). Aggregates were also cultured using Alvetex®
Strata (that has an average pore size of 20 µm) and, similarly, significant numbers of
cells left the aggregate and migrated into the scaffold membrane below (Figure 10B).
Alvetex® Polaris has the smallest average pore size of 3-4 µm, and when aggregates
were cultured for 7 days on these membranes they were maintained intact with no pen-
etration of cells into the membrane (Figure 10A).
Over 7 days culture, aggregates formed flattened tissue-discs and neuroepithelial dif-
ferentiation took place in all tissue-discs examined (arrows, Figure 10). Unlike aggre-
gates cultured in suspension, a necrotic core was not visible at the centre of any tissue-
discs examined cultured using Alvetex®. For all further experiments Alvetex® Polaris
was chosen due to being able to support differentiation within hEC aggregates while
minimising cell loss.
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Figure 9: Histological analysis of TERA2.cl.SP12 aggregates cultured in suspension.
TERA2.cl.SP12 aggregates were maintained in suspension for 21 days and 5 µm paraf-
fin transverse sections were generated and stained using haematoxylin and eosin to
reveal internal structures. Small epithelial cavities that resembled neural rosettes were
visible in many aggregates (arrows) as well as areas of apparent necrosis (asterisks)
with small black cell nuclei visible. Scale bars represent 100 µm (A, C, and E) and 50
µm (B, D, and F). Bright-field images were taken using a Leica ICC50HD microscope


























































































































































































































































































































































































































































































































































































































































3.2.2 Analysis of Apoptosis
The terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay was
performed in order to identify apoptotic cells in TERA2.cl.SP12 aggregates. Aggre-
gates cultured in suspension for 21 days exhibited large numbers of apoptotic cells at
their centre (Figure 11, A-C). Aggregates cultured using Alvetex®Polaris on the other
hand, contained fewer apoptotic cells that were sparsely distributed throughout the ag-
gregate (Figure 11, D-F).
ImageJ was used to quantify the fluorescence intensity of three aggregates maintained
in suspension for 21 days and of one aggregate maintained using Alvetex®Polaris (ex-
amined in two separate locations). Each aggregate was traced around and raw fluo-
rescence intensity (integrated density) of the green channel was divided by the area of
each aggregate to generate corrected fluorescence values for each aggregate. Mean fluo-
rescence intensity of aggregates maintained in suspension was 7.9 (arbitrary units) and
the mean fluorescence intensity of one aggregate maintained using Alvetex®Polaris was
2.2 (arbitrary units) (Figure 12). The difference in mean fluorescence between aggre-
gates cultured in suspension and using Alvetex®Polaris was found to be not statisti-
cally significant (unpaired t-test; P = 0.1354). However, the robustness of this statisti-
cal test is limited due to the very small number of aggregates that could be examined.
Increasing the number of aggregates examined will be necessary in order to be more
confident in determining the differences between aggregate suspension cultures and 3D
tissue-disc cultures in terms of cell viability.
Nonetheless, histological evidence also indicated that some aggregates cultured in sus-
pension developed an hypoxic core (Figure 10). Moreover, TUNEL staining reveals
that the hypoxic core that developed within some aggregates contained large numbers
of apoptotic cells (Figure 11). Possibly due to the limited number of aggregates exam-
ined, the effect of 3D culturing aggregates as tissue-discs using Alvetex®Polaris on the



























































































































































































































































































































Figure 12: Quantification of fluorescent intensity of TUNEL staining in
TERA2.cl.SP12 aggregates maintained in suspension and using Alvetex®
Confocal images of fluorescent TUNEL staining of paraffin sections of TERA2.cl.SP12
aggregates were taken using a Zeiss 510 CLSM. Images were loaded into ImageJ and
each aggregate was traced around. The raw fluorescent intensity (integrated den-
sity) of the green channel was divided by the area of each aggregate to generate cor-
rected fluorescence values for each aggregate. Three different 21 day suspension ag-
gregates were analysed and one aggregate cultured for 14 days in suspension + 7 day
Alvetex®Polaris was analysed in two separate locations. The mean values for sus-
pension and 3D cultured aggregates were plotted with error bars for one standard
deviation.
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3.3 Manipulating Developmental Pathways to Study Aspects
of Human Embryonic Development
Studying the role that developmental pathways play in human embryonic development
is challenging due to the limited accessibility of human embryogenesis in utero. In vitro
differentiation of hESC, hiPSC, and hEC lines allows aspects of human embryonic de-
velopment to be studied. To this end, several morphogens including small molecules
and recombinant proteins were used to manipulate developmental pathways in hEC ag-
gregates in order to attempt to gain insight into the roles of developmental pathways in
human embryonic development using 3D tissue-disc cultured aggregates.
3.3.1 Retinoid Pathway
TERA2.cl.SP12 cultures produce a mixture of terminally differentiated neurons and
non-neural epithelial-like cells when exposed to ATRA in 2D cultures, and the purity of
neural induction is increased in aggregate suspension cultures (Horrocks et al., 2003).
In order to confirm the ability of aggregates cultured using Alvetex®Polaris to respond
appropriately to developmental stimuli, the retinoid pathway was chosen due to its re-
producible induction of neural differentiation in TERA2.cl.SP12 aggregates (Horrocks
et al., 2003; Christie et al., 2008). TERA2.cl.SP12 cells were seeded into suspension
and allowed to form aggregates over 24 hours before being treated with the synthetic
retinoid and ATRA analogue, ec23 [0.01 µM] or DMSO (vehicle control) for 21 days
in suspension. Aggregates cultured in suspension for 21 days were then cultured using
Alvetex®Polaris membranes for a further 7 days. Histological analysis revealed that
DMSO treated aggregates developed small neural rosette structures, while ec23 treated
aggregates appeared more densely packed and neuroepithelial structures were not seen
(Figure 13).
Immunostaining revealed high levels of TUJ1 expression within ec23-treated aggregates
and extensive outgrowth of TUJ1+ neurites into the Polaris membrane (arrows, Figure
14). In DMSO control samples, TUJ1 expression was detected although no neurites
were found to have penetrated the Polaris membrane (data not shown). This indicates
that hEC aggregates responded to retinoid stimulation by ec23 and agreed with pre-
vious findings that ec23 increases neurite outgrowth from TERA2.cl.SP12 aggregates
cultured in 3D in vitro (Clarke et al., 2014).
These data demonstrate that stem cell aggregates cultured as tissue-discs for prolonged
periods can be used to study the role of developmental pathways such as the retinoid

















































































































































































































































































































































































































































































































































































































































































































3.3.2 Bone Morphogenetic Protein activation
Neural differentiation in hEC line TERA2.cl.SP12 in response to retinoid stimulation is
relatively well-studied and highly reproducible in 2D, in aggregate suspension cultures,
and in aggregates cultured as tissue-discs (Horrocks et al., 2003; Christie et al., 2008).
It was also of interest to investigate non-neural differentiation in TERA2.cl.SP12 cells.
The bone morphogenetic protein (BMP) pathway was chosen to be manipulated due
to its ability to inhibit neural differentiation and promote epidermis formation during
vertebrate embryonic ectoderm development (Wilson and Hemmati-Brivanlou, 1995).
BMP2 was chosen as an inducer of hEC aggregates because previous work showed that
it downregulated neural markers and upregulated epithelial markers in TERA2.cl.SP12
cells cultured as aggregates in suspension (Przyborski et al., 2004).
TERA2.cl.SP12 aggregates cultured for 7 days in suspension with BMP2 [50 ngml-1]
followed by 7 days culture using Alvetex®Strata or Polaris membranes responded to
BMP2 stimulation and exhibited distinct morphological features compared to vehicle
(acetic acid) control aggregates (Figure 15). Interestingly, histological analysis re-
vealed heterogeneity in BMP2 treated aggregates, with distinct mesenchymal regions
that contained fewer cells (asterisks, Figure 15), as well as more cell dense regions
with an appearance more similar to vehicle control aggregates (arrows, Figure 15).
CK8 and TUJ1 immunostaining of aggregates treated with BMP2 for 7 days in sus-
pension followed by growth using Alvetex®Polaris for 7 days revealed mutually exclu-
sive expression of pan-epithelial marker CK8 in mesenchymal regions (asterisks, Fig-
ure 16), and TUJ1 expression in cell dense regions (arrows, Figure 16). CK8+;TUJ1−
mesenchymal regions were thought to represent non-neural cell types that were induced
by BMP2 treatment because control aggregates never developed these CK8+ mesenchy-
mal regions. TUJ1+;CK8− cells that were visible after 7 days exposure to BMP2 may
have represented groups of cells that had not yet responded to BMP2 treatment due to
insufficient time for non-neural differentiation to have occurred. To examine this, hEC
































































































































































































































































































































































Figure 16: Immunohistochemical analysis of TERA2.cl.SP12 aggregates treated with
BMP2.
Immunoflourescent staining of sequential 8 µm paraffin transverse sections of hEC ag-
gregates treated with BMP-2 [50 ngml−1] for 7 days revealed CK8 expression, but not
TUJ1 expression, in mesenchymal regions with few cells present (asterisks, B and D).
TUJ1 was found to be expressed in more cell dense regions that expressed minimal lev-
els of CK8 (arrows, A and C). Scale bars represent 50 µm. Confocal images were taken
using a Zeiss 510 CLSM and a 40x objective.
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TERA2.cl.SP12 aggregates treated with BMP2 for 21 days followed by 7 days growth
using Alvetex®Polaris generated large amounts of non-neural, CK8+ mesenchymal tis-
sue (Figure 17E). Notably, however, a region of highly organised neuroepithelial tis-
sue developed at the centre of one large aggregate (Figure 17F). Within the neuroep-
ithelium, mitotically active cells close to the basement membrane expressed the neural
stem cell marker nestin, and mature neural marker TUJ1 expression was increased in
postmitotic cells that lay outside the neuroepithelium (arrows, Figure 18). This stain-
ing pattern agreed with what is known about neurogenesis in vivo (Gotz and Huttner,
2005)—indicating the highly developed and in vivo-like nature of the tissue, but seem-
ingly contradicting the hypothesis that BMP treatment for 21 days would inhibit neu-
ral development.
It was puzzling that such an in vivo-like neuroepithelium developed despite most of
the hEC cells being directed towards non-neural lineages. One explanation considered
was that due to the neural region being enveloped in mesenchymal tissue—and not in
contact with the BMP2-containing media—the default neural pathway for these cells
was instead being followed. However, the fact that neural regions were observed on the
outside of the aggregate (top arrow, Figure 17C), and that the neuroepithelial tissue
in the central region was far more developed than previously seen in TERA2.cl.SP12
aggregates, suggested that a neural inductive effect could also have played a role.
Developmental pathways such as the BMP pathway are tightly regulated. Antagonists
are a common feature of signalling networks such as the BMP pathway, preventing ex-
cessive signal accumulation and maintaining signalling fecundity. Another possibility
was that BMP2 treatment of TERA2.cl.SP12 aggregates induced the production of
BMP inhibitors. Noggin has been shown to be induced in human mesenchymal stem
cells in response to BMP2 (Chen et al., 2012), and is a known neural inducer that acts
by antagonising the neural inhibition of BMPs (Lamb et al., 1993). BMP inhibition
could have been responsible, therefore, for the development of the highly developed
neuroepithelium observed in hEC aggregates treated with BMP2 for 21 days.
Together these data suggest that BMP2 induces differentiation to non-neural cell types
in TERA2.cl.SP12 aggregates cultured as tissue-discs using Alvetex®. However, the




















































































































































































































































































































































































































































































Figure 18: Immunoistochemical analysis of TERA2.cl.SP12 aggregates treated with
BMP2 for 21 days followed by 7 days growth using Alvetex®Polaris.
TERA2.cl.SP12 aggregates were maintained in suspension for 21 days in the presence
of BMP2 [50 ngml−1] followed by a further 7 days 3D culturing using Alvetex®Polaris.
Nestin expression was detected in all cells in the neural region (A), including in TUJ1−
neural progenitor cells that resided close to the basement membrane, some of which
were actively dividing (arrows, B and D). TUJ1 expression was increased in post-
mitotic neurons that lay outside of the neuroepithelium (asterisks, C). Scale bars rep-
resent 20 µm (A, and C), and 10 µm (D, and E). Confocal images were taken using a
Zeiss 880 CLSM and a 63x objective.
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3.3.3 Bone Morphogenetic Protein inhibition
To test the hypothesis that BMP inhibition promoted neuroepithelial differentiation in
TERA2.cl.SP12 aggregates, noggin and dorsomorphin were chosen as developmental
stimuli. Noggin is a cysteine knot protein that acts to inhibit BMP signalling through
ligand sequestration, binding preferentially to BMP4 and BMP7 (Groppe et al., 2002).
Dorsomorphin is a small molecule that was shown to dorsalise zebrafish embryos in
an in vivo screen and antagonises BMP signalling through selective inhibition of BMP
type I receptors ALK2, ALK3, and ALK6 (Yu et al., 2008).
TERA2.cl.SP12 aggregates were treated with BMP inhibitors, dorsomorphin [1 µM]
or noggin [100 ngml−1] (or their respective vehicle controls) for 21 days. Some aggre-
gates were fixed after 21 days in suspension for further analysis while others were main-
tained as tissue-discs using Alvetex®Polaris for a further 7 days. Aggregates treated
with BMP inhibitor dorsomorphin (Figure 19) or noggin (Figure 20) were heteroge-
nous in structure after 21 days in suspension. Aggregates had developed large epithelial
cavities as well as smaller neural rosettes. Close examination of haematoxylin and eosin
stained sections revealed at least two distinct cell morphologies that formed different
epithelial structures. Cells with a more narrow and long nucleus appeared to form neu-
roepithelial rosettes (arrows, Figure 19D), while larger, more cuiboidal cells formed
distinct epithelial cavities (arrow, Figure 19C). No easily discernible differences were
obvious between aggregates treated with dorsomorphin or noggin, or their respective
controls, suggesting that BMP inhibition did not significantly increase neuroepithelial
differentiation in hEC aggregates.
Similar results were seen in aggregates after a further 7 days 3D growth using Alvetex
Polaris. Aggregates formed tissue-discs that contained neuroepithelial tissue (arrow,
Figure 21B) as well as distinct epithelial structures made up of cuiboidal cells (arrow,
Figure 21C). Only results from noggin and vehicle control (BSA) treated aggregates
are shown in the interest of saving space, but dorsomorphin and DMSO-treated aggre-
gates showed similar features.
Immunohistochemistry was undertaken to try to characterise cell types in TERA2.cl.SP12
aggregates and elucidate if any effects on protein expression patterns could be detected
in response to BMP inhibition. Neuroepithelial regions containing neural rosettes were
found to express the neural markers nestin and TUJ1, while they expressed lower levels
of CK8 (Figure 22). Larger epithelial structures expressed lower levels of neural mark-
ers and expressed higher levels of pan-epithelial marker CK8 (Figure 22). Sequential
sections taken from one aggregate treated with dorsomorphin [1 µM] for 21 days in sus-
pension are shown in Figure 22 because they clearly demonstrate the switching be-
tween neural and non-neural epithelial cell types but all aggregates examined showed
similar results.
The development of both neural and non-neural epithelial tissues within hEC aggre-
gates treated with BMP inhibitors dorsomorphin and noggin indicate that BMP inhibi-
tion does not have a strong neural inductive effect in TERA2.cl.SP12 hEC cells.
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Figure 19: Histological analysis of TERA2.cl.SP12 aggregates cultured in suspension
for 21 days in the presence of dorsomorphin
TERA2.cl.SP12 aggregates were cultured in the presence of the BMP inhibitor dorso-
morphin (Dorso) [1 µM] or DMSO (vehicle control) and maintained in suspension for
21 days. Haematoxylin and eosin staining of 6 µm paraffin transverse sections revealed
that DMSO-treated vehicle control aggregates exhibited similar mixed differentiation
to aggregates treated with dorsomorphin. At least two distinct cell types that formed
different epithelial structures were visible within aggregates. Narrow cells produced
neural rosette-like structures (arrows, D, and F) while more cubiodal cells produced
larger epithelial cavities (arrows, C and E). Scale bars represent 100 µm (A, and B),
and 50 µm (C-F). Bright-field images were taken using a Leica ICC50HD microscope
and a 20x (A, and B) or 40x objective (C-F).
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Figure 20: Histological analysis of TERA2.cl.SP12 aggregates cultured in suspension
for 21 days in the presence of noggin
TERA2.cl.SP12 aggregates were cultured in the presence of the BMP inhibitor nog-
gin [100 ngml−1] or bovine serum albumin [0.1%] (vehicle control) and maintained
in suspension for 21 days. Haematoxylin and eosin staining of 6 µm paraffin trans-
verse sections revealed that BSA-treated vehicle control aggregates exhibited similar
mixed differentiation to aggregates treated with noggin. At least two distinct cell types
that formed different epithelial structures were visible within aggregates. Narrow cells
produced neural rosette-like structures (arrows, D and F) while more cuboidal cells
produced larger epithelial cavities (arrow, C and E). Scale bars represent 100 µm (A
and B), and 50 µm (C-F). Bright-field images were taken using a Leica ICC50HD mi-

























































































































































































































































































































































































































































































































































































































































































































































































































































Next, Chiron99021 (Chi) was used to study the role of the canonical Wnt/β-catenin
pathway in TERA2.cl.SP12 differentiation (Przyborski et al., 2004). The small molecule
glycogen synthase kinase 3β (GSK3β) inhibitor, Chi, acts to agonise the canonical
Wnt/β-catenin pathway by blocking the proteolysis of β-catenin and allowing its nu-
clear translocation (Wray et al., 2011). In the nucleus, β-catenin mediates gene-regulatory
effects through interactions with TCF/LEF factors that activate transcription of target
genes when bound to β-catenin (Behrens et al., 1996).
Histological analysis revealed a striking lack of epithelial structures in TERA2.cl.SP12
aggregates treated with Chi [3 µM] for 7 days when compared to vehicle control (DMSO)
treated aggregates (Figure 23). Control aggregates had developed large numbers of
epithelial cavities after 7 days in suspension (mean = 9 cavities per aggregate, n = 4)
while the majority of Chi-treated aggregates completely lacked epithelial structures af-
ter 7 days (mean = 0.2 cavities per aggregate, n = 5). This suggested that epithelial
morphogenesis was strongly inhibited in TERA2.cl.SP12 aggregates by exposure to Chi
[3 µM] for 7 days in suspension and this difference was extremely statistically signifi-
cant (unpaired t-test; P = 0.0008).
Aggregates treated with Chi for 21 days in suspension similarly exhibited a lack of ep-
ithelial structures compared to DMSO controls (Figure 24) (Chi-treated mean = 1.2
cavities per aggregate, n = 7; control mean = 8.5 per aggregate, n = 4; unpaired t-test;
P = 0.0012). Interestingly, Chi-treated aggregates were also substantially larger than
control aggregates (Chi mean diameter = 801 µm, n = 3; control mean diameter = 349
µm, n = 4; unpaired t-test; P = 0.0064). A large central cavity that was devoid of
cells was seen in some aggregates (asterisk, Figure 24B). These cavities may have rep-
resented a necrotic core of cells that developed due to the increased size of the aggre-
gates, or an artefact of the process of aggregates adhering together that has previously
been shown to produce such hole defects (Beachley et al., 2014). It was interesting to
note whorls of cells that formed a circular cluster in some Chi-treated aggregates main-
tained in suspension for 21 days (arrows, Figure 24B&D). These circular clusters of
cells were thought to have developed as a consequence of blocking epithelial morpho-
genesis in TERA2.cl.SP12 cells.
Aggregates treated with Chi for 21 days in suspension and maintained on Alvetex®Polaris
for a further 7 days also showed highly reduced epithelial tissue development. A typ-
ical example is shown where only one cavity could be seen in a Chi-treated aggregate
and 9 in a control aggregate (Figure 25). The development of highly reduced numbers
of epithelial structures in Chi-treated aggregates maintained in suspension and using
Alvetex®further supported that epithelial differentiation is reduced in response to Chi.
These data suggest that the canonical Wnt/β-catenin pathway plays a role in epithelial
morphogenesis in TERA2.cl.SP12 aggregates. It was not immediately obvious whether
Chi-treatment led to other changes in differentiation, however, and so immunohisto-
chemistry was used to characterise protein expression in Chi-treated aggregates.
Only aggregates after 21 days in suspension were chosen for immunohistochemical anal-
ysis to allow for a greater number of aggregates to be examined per slide. Expression
of the neural markers nestin and TUJ1 was seen in aggregates treated with Chi for 21
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Figure 23: Histological analysis of TERA2.cl.SP12 aggregates treated with Chi-
ron99021 for 7 days in suspension
TERA2.cl.SP12 aggregates were maintained in suspension in the presence of Chi-
ron99021 (Chi) [3 µM] for 7 days and histological analysis carried out. Haematoxylin
and eosin staining revealed that small neural rosette-like structures that developed in
control aggregates (A, and arrows in C) were absent in Chi-treated aggregates (B, and
D). Scale bars represent 100 µm (A, and B), and 50 µm (C, and D). Bright-field images
were taken using a Leica ICC50HD microscope and 20x (A, and B), or 40x objective
(C, and D).
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Figure 24: Histological analysis of TERA2.cl.SP12 aggregates treated with Chi-
ron99021 for 21 days in suspension
TERA2.cl.SP12 aggregates were maintained in suspension in the presence of Chi-
ron99021 (Chi) [3 µM] for 21 days and histological analysis performed. Haematoxylin
and eosin stained paraffin transverse sections revealed that large epithelial structures
that developed in control aggregates (A, and C) were absent in Chi treated aggre-
gates and epithelial structures were rarely seen (B, and D). A large central cavity
was evident in some Chi-treated aggregates (asterisk, B) that was thought to repre-
sent a necrotic core or hole defects due to the process of smaller aggregates adhering
together. A circular whorl of cells was sometimes visible in Chi-treated aggregates (ar-
rows, B and D) that was thought to be induced by Chi treatment blocking epithelial
morphogenesis. Scale bars represent 200 µm (B), 100 µm (A), and 50 µm (C, and D).
Bright-field images were taken using a Leica ICC50HD microscope and a 10x (B), 20x








































































































































































































































































































































































































































days in suspension (Figure 26). CK8 expression, however, was absent from all aggre-
gates examined (Figure 26A). As was previously noted, a proportion of aggregates
were found to contain small epithelial structures and these were found to be CK8− but
expressed nestin. The staining pattern observed is therefore indicative of the develop-
ment of neuroepithelial tissue in Chi-treated TERA2.cl.SP12 aggregates.
Together these data reveal that Chi has a strong inhibitory effect on epithelial tissue
formation in TERA2.cl.SP12 aggregates. However, Wnt/β-catenin activation does not





















































































































































































































































































































































3.4 TERA2.cl.SP12 Teratoma formation
In order to compare the tissues produced in vitro to tissues produced in vivo, teratoma
formation from TERA2.cl.SP12 cells was examined. Teratoma samples were derived
from an animal study that was previously performed with permission of the institution
at Durham University, UK, School of Biological and Biomedical Sciences, in accordance
with UK Home Office guidelines. 0.5x106 undifferentiated TERA2.cl.SP12 cells were
implanted subcutaneously into the flank of adult male nude (nu/nu) mice and formed
teratomas over 6-8 weeks.
Histological analysis of teratomas revealed multiple distinct differentiated cell types
and formed complex epithelial tissues including neuroepithelium (arrows, Figure 27B&C),
and larger non-neural epithelial structures that have previously been shown to express
CK8 (asterisks, Figure 27D-F)(Cooke et al., 2006). Epithelial tissues seen in hEC
teratomas were well developed but overall tissue organisation was haphazard (Figure
27A).
Comparatively speaking, epithelial tissue structures were generally larger and more de-
veloped than those seen in aggregates cultured in vitro, possibly due to interactions
with host vasculature or the larger size and greater cell number in teratomas. However,
neuroepithelium that developed in one BMP2-treated aggregate cultured as a tissue-
disc (17) was at least as highly developed as those seen in teratomas, suggesting that
under certain conditions in vitro culturing of hEC aggregates as tissue-discs for ex-
tended periods provides a suitable microenvironment to allow differentiation to occur
in a manner comparable to in vivo.
It has been shown that TERA2.cl.SP12 cells could be maintained in an undifferentiated
state in culture and that their spontaneous differentiation was induced by aggregation.
The culturing of hEC aggregates as 3D tissue-discs using Alvetex®Polaris facilitated
the formation of a flattened tissue-disc that reduced the formation of a necrotic core
over prolonged culture. Tissues produced in hEC tissue-discs included neuroepithelial
tissue and other non-neural epithelial tissues that were similar to tissues produced in
teratomas in vivo. Culturing human stem cell aggregates for extended periods in vitro
as tissue-discs using Alvetex®Polaris may, therefore, offer a novel alternative to the




















































































































































































































































































































































































































































3.5 Mouse Embryonic Stem Cell Line CGR8
CGR8 mESCs were chosen for validation of the method of using stem cell aggregates
cultured as tissue-discs using Alvetex® 3D scaffold membranes as a novel in vitro pluripo-
tency assay. CGR8 cells were maintained feeder-free in 2D culture with the addition of
LIF to the media to prevent spontaneous differentiation (Williams et al., 1988). Im-
munocytochemistry revealed that markers typically associated with pluripotency in
mESCs including SSEA-1 (Solter and Knowles, 1978), Nanog (Chambers et al., 2003),
Oct4 (Scholer et al., 1989), and SOX2 (Yuan et al., 1995) were expressed in colonies
of CGR8 mESCs grown in 2D culture (Figure 28). CGR8 cells also exhibited mor-
phological features typical of mESCs including small size, rounded morphology, high
nuclear:cytoplasm ratio, and prominent nucleoli. As an initial in vitro characterisation,
these findings were indicative of the pluripotency of CGR8 mESCs maintained in 2D
culture.
3.6 Murine Embryoid Bodies
CGR8 mESCs were formed into aggregates or embryoid bodies (mEBs) using AggreWell
plate technology. The benefits of using such a method to aggregate cells over sponta-
neous aggregation is that the size of EBs and number of cells per EB can be regulated
more precisely. mEBs containing 1000 cells were cultured in suspension in the pres-
ence of 10% fetal bovine serum (FBS) and underwent cavitation after 5 days. Cavi-
ties were visible in most aggregates in suspension under phase-contrast microscopy as
lighter coloured areas, and as cavities in haematoxylin and eosin stained sections (aster-
isk, Figure 29D&E). Several differentiated cell types were visible within mEBs after
5 days suspension culture (arrow, Figure 29F) and appeared to form an extrusion of
cells on the surface of many mEBs (arrow, Figure 29C).
These initial mEB experiments were conducted using relatively late passage number
stocks of the CGR8 mESC cell line (passage number 26, p26). In order to maintain
the greatest level of developmental potency cells of as early passage number as possible
should be used. Passage number 9 stocks (p9) of the CGR8 cell line were also used to
generate mEBs that were subsequently cultured in suspension with 20% FBS to try to
maximise spontaneous differentiation.
Histology was performed on p9 mEBs cultured in 20% FBS after 5 days suspension cul-
ture and images of haematoxylin and eosin stained 6 µm paraffin transverse sections
are shown in (Figure 30). Similar to p26 mEBs, large cystic cavities were seen in the
majority of mEBs examined (Figure 30A). Differentiated cell types were also visi-
ble and had formed an extrusion of cells on the surface of many aggregates (Figure
30B). Unlike mEBs cultured in 10% FBS, however, large areas of mesenchymal tissue
were seen that resembled embryonic mesenchyme (Figure 30C)—a mesoderm-derived
transitional tissue formed during mouse embryonic development that contains stellate-
shaped cells and facilitates nutrient transfer (Greep and Weiss, 1977). p9 mEBs cul-
tured with 20% FBS were larger than p26 mEBs cultured with 10% FBS, possibly due
to reduced cell density within aggregates (mean diameter p9 mEBs = 679 µm, n = 7;
mean diameter p26 mEBs = 383 µm, n = 11; unpaired t-test; P = 0.0013).
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Figure 28: Pluripotency marker expression in CGR8 mESCs cultured in 2D.
Immunocytochemistry revealed expression of the pluripotency markers SSEA-1, Nanog,
Oct4, and SOX2 in CGR8 mESCs cultured in 2D in the presence of LIF. Phase-
contrast images revealed typical mESC morphology including small size, rounded
morphology, high nuclear:cytoplasm ratio, and prominent nucleoli. Scale bars represent
100 µm. Phase-contrast and flourescent images were taken using a Leica DMI3000B



































































































































































































































































































































































































































































































































































































































































































































To identify the differentiated cell types that had formed in mEBs after 5 days in sus-
pension, immunohistochemistry was employed. Immunostaining against E-cadherin
(E-cad), GATA4, and collagen-IV (col-IV) indicated the development of endodermal
lineages in p26 and p9 mEBs cultured with 10% and 20% FBS, respectively. E-cad+
epithelial cells partially covered the surfaces of mEBs, frequently covering an extru-
sion of cells at the surface, and also formed rudimentary internal epithelial structures
or small clusters of E-cad+ cells (Figure 31A&D and Figure 32). Col-IV staining
was frequently observed in association with E-cad+ cells, suggesting that these epithe-
lial cells produced a basement membrane (Figure 31C&F and Figure 34). GATA4
was expressed in many cells within E-cad+ epithelial regions of mEBs, including inter-
nal epithelial structures and external epithelial coverings (Figure 31B&E and Figure
33). Interestingly, col-IV expression was also seen in some E-cad− regions (asterisk ,
Figure 34A&C), and one region of external epithelial tissue covering one p9 mEB had
not produced a basement membrane (asterisk, Figure 34D).
The E-cad+;GATA4+;col-IV+ epithelial cells identified in mEBs after 5 days suspen-
sion culture were indicative of visceral or definitive endoderm development—as both
endodermal lineages share the expression of many genes inlcuding E-cad, GATA4, and
col-IV (Rojas et al., 2010). Using only these markers, however, it was difficult to de-
termine the exact identity of these endodermal tissues. It was likely that multiple lin-
eages had developed because not all of the cell populations identified shared the same
characteristics (e.g. produced a basement membrane) or showed expression of all three
markers. GATA4 expression was detected in many cells of the mesenchyme that devel-
oped within p9 mEBs (arrows, Figure 33A), which is consistent with in vivo analy-
ses where GATA4 is expressed in the embryonic mesoderm (Arceci et al., 1993; Rojas
et al., 2010). Immunostaining, therefore, indicated the development of endodermal and
mesodermal lineages.
Some mEBs were also maintained for longer periods in suspension. After around 9 days
in suspension, spontaneous pulsatile contractions within p9 mEBs became apparent un-
der phase-contrast microscopy. Spontaneous contraction was observed in the majority
of mEBs after 9 days in suspension (71%, n = 14). Cardiomyocte differentiation and
spontaneous contraction is a well-known phenomenon in mEBs and has been reported
previously (Doevendans et al., 2000). Phase-contrast images of mEBs in suspension
revealed that contractile activity occurred in regions of reduced cell density where ag-
gregates appeared translucent (black asterisk, Figure 35). mEBs also contained more
cell dense regions that appeared opaque under phase-contrast microscopy and were
non-contractile (white asterisk, Figure 35). In one mEB, a band of contractile cells
appeared to have formed a tube that contracted in unison (arrows, Figure 35A&D).
Unfortunately, these samples were lost and further histological analysis was unable to
be performed.
It was interesting that contractions originated from less cell dense regions that may
have corresponded to embryonic mesenchyme identified in haematoxylin and eosin stained
sections of 5 day p9 mEBs (Figure 30). GATA4 is expressed early in cardiomyocyte
differentiation and is important for cardiac development (Arceci et al., 1993). GATA4
expression that was detected in a proportion of cells in the mesenchyme of p9 mEBs af-
ter 5 days in suspension may be indicative of early cardiomyocyte differentiation that
later resulted in spontaneous contractions.
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Together, these data reveal that mEB formation from CGR8 mESCs induces sponta-
neous differentiation towards mesodermal and endodermal lineages. In order to deter-
mine the development potential of mEBs cultured as tissue-discs for extended periods,

































































































































































































































































































































































Figure 32: E-cadherin expression in p9 mEBs after 5 days suspension culture.
Immunostaining against E-cadherin (E-cad) was performed on 6 µm paraffin transverse
sections of p9 CGR8 mEBs cultured in suspension with 20% FBS for 5 days. E-cad was
expressed in cells that partially covered the exterior of mEBs (arrows, A, and asterisk,
D) as well as in a small number of cells within cell dense regions of aggregates (arrows,
B, and D). Scale bars represent 50 µm (A, and B) and 20 µm (C, and D). Images were
taken using a Zeiss 880 CLSM using a 20x (A, and B) and 63x objective (C, and D).
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Figure 33: GATA4 expression in p9 mEBs after 5 days suspension culture.
Immunostaining against GATA4 was performed on 6 µm paraffin transverse sections
of p9 CGR8 mEBs cultured in suspension with 20% FBS for 5 days. GATA4 was
expressed in the majority of E-cad+ epithelial cells that formed external epithelial cov-
erings of mEBs (arrows, C, and asterisk, D) and a small number of cells in cell dense
regions (arrows, C, and D) that corresponded to E-cad+ cells that were observed in
these regions. GATA4 expression was also detected in a proportion of cells in mes-
enchymal regions within mEBs (arrows, A). Scale bars represent 50 µm (A, and B) and
20 µm (C, and D). Images were taken using a Zeiss 880 CLSM using a 20x (A, and B)
and 63x objective (C, and D).
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Figure 34: Collagen-IV expression in p9 mEBs after 5 days suspension culture.
Immunostaining against collagen-IV (col-IV) was performed on 6 µm paraffin trans-
verse sections of p9 CGR8 mEBs cultured in suspension with 20% FBS for 5 days. Col-
IV staining was detected in external and internal regions that were E-cad+;GATA4+
indicating that these epithelial cells had produced a basement membrane (arrows in A,
B, C, and D). However, one external epithelial covering was found to not express col-IV
(asterisk, D), and col-IV staining was seen in other regions that did not express E-cad
(asterisk, A and C). Scale bars represent 50 µm (A, and B) and 20 µm (C, and D).
















































































































































































































































































































































3.6.1 Murine Embryoid Bodies Cultured Using 3D scaffolds
p26 mEBs were cultured in suspension with 10% FBS for 5 days followed by a further
14 days culture using Alvetex®Scaffold (40 µm average pore size), Strata (20 µm av-
erage pore size), and Polaris (4 µm average pore size). Cells migrated long distances
away from aggregates within the scaffold of mEBs cultured using Alvetex®Scaffold
and Strata (Figure 36). It was evident from haematoxylin and eosin stained paraffin
transverse sections that cells from aggregates cultured using Alvetex®Scaffold migrated
significantly further (mean = 4475 mm, n = 4) than cells from aggregates cultured us-
ing Alvetex®Strata (mean = 1425 mm, n = 3) and this difference was found to be ex-
tremely statistically significant (unpaired t-test; P < 0.0001). Similar to hEC aggre-
gates, mEBs developed into an intact tissue-disc when cultured using Alvetex®Polaris,
with no evidence of cells penetrating the membrane below (asterisks, Figure 37A&D).
Organised tissue structures could be identified by routine histology and qualitative
observation of p26 mEBs cultured using Alvetex®Polaris. Internal cavities lined with
cuboidal epithelial cells were seen (asterisks, Figure 37C&F). These epithelial cavities
may have represented the development of extraembryonic structures such as the yolk
sac, or alternatively, embryonic structures such as the primitive gut tube (Rojas et al.,
2010). Distinct epithelial cell types including columnar epithelial cells were located at
the external surface of some aggregates and in one aggregate formed villi (asterisks,
Figure 37B&D)(Bosse et al., 2006). Proteinaceous regions were associated with ep-
ithelia (arrows, Figure 37C&F) and were thought to represent mesodermal connec-
tive tissues that support epithelial tissues during embryonic development (Rojas et al.,
2010).
Immunohistochemical analysis confirmed mesodermal differentiation through detection
of α-smooth muscle actin (αSMA) expression in supportive connective tissue underly-
ing internal epithelial cavities and in a small number of cells throughout the aggregate
(Figure 38B&D). Ectodermal differentiation was indicated through positive staining
for the neural marker TUJ1 (Figure 38A&C). However, the morphology of TUJ1+
cells seemed inconsistent with neuroectodermal development and neuroepithelial struc-
tures were absent. It is also possible that TUJ1 expression reflected the development
of the testis (as CGR8 is a male mESC line) or of highly proliferative cells, that both
express β-III-tubulin (De Gendt et al., 2011; Katsetos et al., 2003; Ferrandina et al.,
2006).
In further experiments mEBs were maintained using Alvetex®Polaris because it was
shown to promote formation of an intact tissue-disc that supported the development of




































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 38: Immunohistochemical analysis of mEBs after 5 days suspension culture
followed by 14 days growth using Alvetex®Polaris.
Immunostaining against TUJ1 and αSMA in 8 µm paraffin transverse sections
of p26 mEBs cultured for 5 days in suspension followed by 14 days growth using
Alvetex®Polaris indicated neurectodermal and mesodermal differentiation, respec-
tively. TUJ1+ cells were located in a small cluster (arrow, A) and were not typically
neural in appearance with no evidence of neuroepithelial structures (C). αSMA staining
was seen in a layer of connective tissue below an internal epithelial cavity (arrow, D) as
well as in individual cells throughout the aggregate (arrow, B). Scale bars represent 100
µm (A, and B) and 50 µm (D), and 20 µm (C). Images were taken using a Zeiss 510
CLSM and a 20x (A and B) and 40x (C, and D) objective.
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p9 mEBs that were maintained in suspension for 5 days with 20% FBS were grown as
tissue-discs using Alvetex®Polaris. Histological analysis of one p9 mEB maintained as
a tissue-disc for 16 days revealed the development of tissues representative of all three
emrbyonic germ layers. Haematoxylin and eosin staining alongside Masson’s trichrome
staining facilitated the identification of internal endoderm-like epithelial tissue (aster-
isk, Figure 39B&E), mesodermal connective tissue (asterisk, Figure 39C&F), and
an ectodermal keratin pearl (arrow, Figure 39C&F). Immunohistochemical analysis
was used to examine tissue-specific marker expression in p9 mEBs cultured as tissue-
discs for 16 days.
Columnar endoderm-like epithelial cells that developed in p9 mEBs after 16 days were
E-cad+ and supported by mesodermal connective tissue that contained α-SMA+ fibrob-
lastic cells, as is typically observed in the lamina propria underlying endodermal ep-
ithelial tissues in vivo (Figure 40A&B) (Storch et al., 2007; Young et al., 2000). The
endodermal lineage that the epithelium derived from was difficult to identify histolog-
ically because there are a large number of embryonic and extraembryonic endodermal
epithelial structures that exhibit similar features. E-cad staining supported histological
evidence that a keratin pearl was seen (Figure 40C). However, staining for epidermal
keratins such as keratin-14 would have been useful to investigate the developmental ori-
gins of the tissue further.
Immunohistochemical analysis suggested that complex tissues representative of all three
embryonic germ layers developed in p9 mEBs cultured as tissue-discs for 16 days using
Alvetex®Polaris. Next, p9 mEBs were maintained for up to 32 days using Alvetex®Polaris

























































































































































































































































































































































































































































































































































































































































































































































































































































































































One p9 mEB that was maintained for 32 days using Alvetex®Polaris after 5 days in
suspension developed to a significant size (2.3 mm in length and 946 µm in height)
and contained a large cystic cavity with a diameter of 685 µm (asterisk, Figure 41).
Histological analysis of this mEB revealed complex tissues including large amounts
of collagenous fibrous connective tissue (Figure 42A&D), endoderm-like epithelium
(Figure 42B&E), and neuroepithelium (Figure 42C&F).
Connective tissues that developed contained large amounts of collagen as indicated by
blue staining in Masson’s trichrome (Figure 42A&D). Cells were sparsely distributed
through the collagenous ground substance that resembled the structure of elastic or
hyaline cartilage that contains sparsely distributed chondrocytes contained within la-
cunae (Greep and Weiss, 1977). Alizarin Red staining was performed to investigate
whether mineralisation of the connective tissue had occurred—which would have been
indicative of early osteogenesis—but staining failed to identify any calcium deposition
(data not shown).
Immunohistochemistry was employed to investigate the structure more closely of the
endoderm-like epithelium identified in histologic sections. Immunostaining and high-
resolution confocal microscopy revealed granules within cells that resembled mucin-
containing granules found in goblet cells of secretory epithelia (arrows, Figure 43B&C)
(Diaspro et al., 2006), suggesting that the epithelial tissue represented a secretory en-
dodermal epithelium such as those lining the digestive and respiratory tracts (Greep
and Weiss, 1977). Alternatively, the granules identified may also have represented vac-
uoles that are frequently observed in visceral endoderm (Wada et al., 2013). Analysis
of tissue-specific markers such as muc2 (a marker of goblet cells) would be useful in
order to identify the specific endodermal lineage that the endoderm-like epithelium de-
rived from.
Immunohistochemistry was also used to detect neural marker TUJ1 expression in the
region of tissue that resembled neuroepithelium. A neural rosette of TUJ1− neuroep-
ithelial cells was visible (asterisks, Figure 44B&C) that was surrounded by TUJ1+
mature neural cells (arrows, Figure 44B&C), demonstrating the in vivo-like nature of
the neuroepithelium (Gotz and Huttner, 2005).
Culturing p9 mEBs for 5 days in suspension followed by 32 days using Alvetex®Polaris
increased the diversity and complexity of differentiated tissues that developed in com-
parison to aggregates cultured for 16 days. Qualitative analysis of one 32 day mEB
facilitated identification of highly complex differentiated tissues representative of all
three germ layers including connective tissue, endodermal epithelium, and neural tissue.
Taken together, these findings suggest that maintaining mEBs for extended periods
as tissue-discs allows differentiation into complex in vivo-like tissues representative of
all three germ layers. Maintenance of stem cell aggregates using 3D polystyrene scaf-
folds therefore offers a novel in vitro differentiation technique that may be used as an
in vitro pluripotency assay.
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Figure 41: Gross morphology of one p9 mEB cultured for 5 days in suspension and
then 32 days using Alvetex®Polaris.
Haematoxylin and eosin stain (A) and Masson’s trichrome stain (B) of 8 µm paraffin
transverse sections of one p9 mEB cultured for 5 days in suspension with 20% FBS
followed by 32 days growth using Alvetex®Polaris. The aggregate grew to a substantial
size with a length of 2.3 mm and a maximum height from the membrane of 946 µm.
The aggregate contained a large epithelial cavity with a diameter of 685 µm (asterisks)
and large amounts of collagenous connective tissue that appeared blue in Masson’s
trichrome stain (B). Scale bars represent 500 µm. Bright-field images were taken using












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.7 Manipulating Developmental Pathways to Direct Stem
Cell Fate
A major goal in modern developmental and stem cell biology is to direct the differen-
tiation of pluripotent stem cells to pure populations of defined somatic cell types in
vitro that may be used for cell replacement therapies or for disease modelling and drug
discovery (Murry and Keller, 2008). It was examined whether differentiation in CGR8
mEBs could be directed to specific lineages through manipulation of signalling path-
ways that are known to be important during embryonic development.
3.7.1 Bone Morphogenetic Protein Pathway
The BMP signalling pathway is pleiotropic during development and exhibits induc-
tive or inhibitory effects in the specification of many somatic lineages (Li and Chen,
2013). BMP4 is indicated in the specification of the primitive streak and mesendoder-
mal lineages and has been shown to reduce neural progenitor formation in mEBs (Fin-
ley et al., 1999). In the default model of neural plate specification, BMP inhibitors are
required signals from the organiser to induce neural tissue in the embryonic ectoderm
(Spemann and Mangold, 1924; Ozair et al., 2013).
To examine the effect of BMP inhibition on mESC differentiation, mEBs were main-
tained in suspension for 5 days with 20% FBS and in the presence of a small molecule
antagonist of BMP signalling, dorsomorphin [1 µM]. Dorsomorphin elicits effects through
selective inhibition of BMP type I receptors ALK2, ALK3, and ALK6 (Yu et al., 2008).
Haematoxylin and eosin staining revealed stark differences between DMSO control and
dorsomorphin-treated mEBs. DMSO control aggregates contained cystic cavities and
mesenchymal regions that were typical of untreated mEBs (asterisks, Figure 45C).
Dorsomophin-treated mEBs, however, were smaller than control mEBs (dorsomor-
phin mean diameter = 398 µm, n = 3; DMSO mean diameter = 672 µm, n = 3; un-
paired t-test; P = 0.011), appeared more cell dense, and the majority failed to undergo
cavitation (66%, n = 3), as has previously been reported (Coucouvanis and Martin,
1999) (Figure 45B). Small neuroepithelial structures were seen that resembled neural
rosettes (arrows, Figure 45D), and immunohistochemistry was undertaken to examine
the expression of neural markers.
Immunostaining revealed many small isolated regions of TUJ1 expression throughout
dorsomorphin-treated aggregates that were not seen in DMSO control aggregates (ar-
rows, Figure 45A&B, and data not shown). Typical neural rosettes were seen that
were weakly positive for TUJ1 (asterisks, Figure 46C&D) and surrounded by more
mature neurons that were strongly TUJ1+ (arrows, Figure 46C&D).
These data reveal that differentiation could be directed towards neurectodermal lin-
eages in mEBs in response to BMP inhibition. Next, dorsomorphin-treated mEBs were
maintained as tissue-discs for extended periods using Alvetex®Polaris to determine the
effect of prolonged culture on differentiation.
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Figure 45: Histological analysis of p9 mEBs maintained in suspension for 5 days in
the presence of dorsomorphin.
p9 mEBs were maintained in suspension with 20% FBS and [1 µM] dorsomorphin (or
DMSO control) for 5 days and 6 µm paraffin transverse sections stained with haema-
toxylin and eosin. DMSO control aggregates (A, and C) underwent cavitation and
developed mesenchymal regions (asterisks, C). Dorsomorphin-treated aggregates, how-
ever, failed to undergo cavitation in the majority of cases and formed smaller, more cell
dense mEBs (B, and D). Neural rosette-like structures were seen, indicative of neurec-
todermal development (arrows, D). Scale bars represent 200 µm (A), 100 µm (B, and
C), and 50 µm (D). Bright-field images were taken using a Leica ICC50HD microscope
and a 10x (A), 20x (B, and C), or 40x objective (D).
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Figure 46: Immunohistochemical analysis of neural marker expression in
dorsomorphin-treated mEBs after 5 days in suspension.
Immunostaining against neural marker TUJ1 was performed on 6 µm paraffin trans-
verse sections of p9 mEBs maintained in suspension with 20% FBS in the presence
of BMP antagonist dorsomorphin [1 µM]. TUJ1 expression was detected in isolated
regions throughout mEBs after 5 days exposure to dorsomorphin (arrows, A and B).
Typical neural rosettes were seen that were weakly positive for TUJ1 (asterisks, C and
D) and surrounded by mature neurons that expressed TUJ1 strongly (arrows, C and
D). Scale bars represent 50 µm (A, and B), and 10 µm (C, and D). Confocal images
were taken using a Zeiss 880 CLSM and a 20x (A, and B), or 63x objective (C, and D).
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p9 mEBs maintained in suspension for 5 days with 20% FBS and [1 µM] dorsomorphin
were maintained using Alvetex®Polaris for 16 - 32 days. Histological analysis revealed
that dorsomorphin-treated mEBs cultured as tissue-discs failed to develop endoderm-
like epithelial tissues or mesodermal connective tissues that were prominent in DMSO-
treated controls (Figures 47&48). This striking effect was seen in the majority of
mEBs treated with dorsomorphin [1 µM] for 5 days followed by 16 or 32 days growth
using Alvetex®Polaris (60%, n = 5).
In two mEBs examined, however, dorsomorphin appeared to have no affect on differ-
entiation and there were no discernible differences compared to DMSO control mEBs.
Large amounts of endoderm-like epithelium and mesodermal connective tissue was seen
in one dorsomorphin-treated mEB maintained as a tissue-disc for 32 days (Figure 49).
In haematoxylin and eosin stained transverse sections, eosinophilic enucleated bicon-
cave discs were observed that resembled erythrocytes (arrows, Figure 49C&F) and
had a mean diameter of 7.08 µm (n = 24) that is in agreement with the known diame-
ter of erythrocytes of 7-7.2 µm (Young et al., 2000). Some of these cells were nucleated
that is a feature of erythrocytes generated during yolk sac primitive haematopoiesis
(Figure 49C&F). Interestingly, before tissue-discs were processed, a red colouration
within some mEBs was observed and it was thought that media trapped within a cys-
tic cavity could be responsible. However, the ability of mEBs to spontaneously gen-
erate blood-islands and embryonic erythrocytes is a well-known phenomenon and red
colouration within mEBs has also been observed (Doetschman et al., 1985; Wang et al.,
1992). This suggests that haematopoiesis occurred in mEBs cultured as tissue-discs but
further analysis is required in order to confirm this.
Immunohistochemistry revealed TUJ1 expression in cells within some mEBs treated
with dorsomorphin [1 µM] for 5 days and cultured for 16 days (arrow, Figure 50A) or
32 days using Alvetex®Polaris (arrow, Figure 51A), confirming that neural differen-
tiation occurred in these mEBs. Infiltration of large numbers of TUJ1+ neurites into
the membrane below mEBs was observed (arrows, Figure 50C, and Figure 51B).
However, many cells within mEBs did not express TUJ1 and in some cases developed
into structures with non-neural morhology on the exterior of mEBs (asterisks, Fig-
ure 51B&C)). Further analysis of tissue-specific markers will be necessary in order
to identify these non-neural cell types. Flow cytometry or other quantitative tech-
niques should be performed to quantify the ratio of neural to non-neural cells induced
in tissue-discs in response to dorsomorphin.
These data indicate that mESC differentiation can be robustly directed to neural lin-
eages in tissue-discs through inhibition of BMP signalling by dorsomorphin. The ability









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Chiron99021 (Chi) was utilised as an exogenous agonist of canonical Wnt/β-catenin
signalling. Chi agonises the canonical Wnt pathway by inhibiting GSK3β and pre-
venting the proteolytic degradation of β-catenin and allowing its nuclear translocation
where it acts as a transcriptional co-regulator (Wray et al., 2011; Behrens et al., 1996).
p9 mEBs were maintained in suspension for 5 days with 20% FBS and Chi [3 µM].
Haematoxylin and eosin staining of paraffin transverse sections failed to reveal any
overt differences between Chi-treated mEBs and DMSO controls (Figure 52). Culture
time was therefore extended using Alvetex®Polaris for 16-32 days to determine if any
effect on differentiation in response to Chi was apparent after a longer culture period.
After 16 days or 32 days culture using Alvetex®Polaris, a proportion of tissue-discs
examined (50%, n = 4) failed to develop the large internal epithelial cavities that were
typically observed in controls, and had a flatter and thinner morphology compared to
control aggregates (Figure 53). One tissue-disc cultured for 16 days produced large
amounts of connective tissue (arrow, Figure 53C), and also contained large regions
of what appeared to be apoptotic cells (asterisk, Figure 53C). In contrast, connective
tissue appeared absent in one mEB cultured for 32 days using Alvetex®Polaris and a
layer of squamous epithelial cells or fibroblasts was seen at the exterior surface of the
aggregate (arrow, Figure 53F).
Large internal epithelial cavities and connective tissues developed in 50% of mEBs ex-
amined that appeared similar to DMSO control mEBs (Figure 54). The fact that
some mEBs appeared to be unaffected by Chi treatment added weight to the hypoth-
esis that some mEBs were resistant to directed differentiation. It would be interesting
to increase the number of aggregates examined and to quantify more rigorously what
percentage of mEBs responded to treatment and whether this could be manipulated
through altering the concentration of inducer or mEB size.
Together these data agree with what was previously observed in hEC aggregates and
suggest that the canonical Wnt/β-catenin pathway inhibits the development of epithe-
lial cavities in mEB-derived tissue discs cultured for up to 32 days.
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Figure 52: Histological analysis of p9 mEBs maintained in suspension for 5 days in
the presence of Chiron99021.
p9 mEBs were maintained in suspension with 20% FBS and [3 µM] Chiron99021 (Chi)
(or DMSO control) for 5 days and 6 µm paraffin transverse sections stained with
haematoxylin and eosin. Chi-treated aggregates and DMSO controls both contained
an array of differentiating cell types and developed internal cavities (asterisks, C) and
mesenchymal regions. Scale bars represent 200 µm (A, and B), 100 µm (C), and 50 µm
(D). Bright-field images were taken using a Leica ICC50HD microscope and a 10x (A,



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.8 Murine Embryonic Stem Cell Teratomas
Teratoma formation from CGR8 mESCs was examined in order to compare tissues that
developed in vitro in tissue-discs to tissues produced in vivo in teratomas. Teratoma
samples were derived from a previous animal study that was performed as part of a
collaboration between Durham University, UK, School of Biological and Biomedical
Sciences, and Newcastle University, UK, Institute of Genetics, with permission from the
institutions and in accordance with UK Home Office guidelines.
1x106 CGR8 mESCs were implanted subcutaneously into the flank of adult female
nude (nu/nu) mice and formed teratomas over 28 days. Histological analysis was per-
formed on paraffin transverse sections that contained an array of highly complex differ-
entiated tissues representative of all three embryonic germ layers.
Ectodermal tissues developed including a large region of epidermal tissue that con-
tained keratinocytes (arrow, Figure 55B), cornified layers of keratin (arrow, Figure
55E), hair follicles (asterisks, Figure 55C&F) with associated sebaceous glands (ar-
row, Figure 55F), and subcutaneous adipose tissue (asterisk, Figure 55A). Neu-
roepithelium also developed and typical neural rosettes were seen (arrows, Figure
56C&F). Mesodermal derivatives included hyaline cartilage that was identified with
one or two chondrocytes that resided within lacunae (arrows, Figure 57C&F) and
were surrounded by collagenous ground substance, as well as striated muscle and adi-
pose tissue (data not shown). Calcium mineralisation was detected in a tissue that re-
sembled trabecular bone (Figure 58). Endodermal epithelial tissue was observed that
formed an internal cavity (asterisks, Figure 59B&E) and included columnar epithelial
cells that resembled absorptive enterocytes with microvilli (arrows, Figure 59C&F),
indicative of gastrointestinal epithelium.
It is not surprising that, comparatively speaking, the complexity and integrity of tis-
sues seen in teratomas was greater compared to mEBs cultured as tissue-discs using
Alvetex®Polaris. It is well established that the in vivo environment provides nutri-
tional support through host vascularisation, supporting differentiation and facilitat-
ing the development of highly complex tissues (Przyborski, 2005). In addition, ter-
atomas initially contained a 10-fold greater number of cells compared to mEBs and this
may have provided enhanced cell interactions that are essential for tissue development.
Taken together these findings confirm the pluripotency of CGR8 mESCs and indicate
the ability of CGR8 mESCS to develop into complex tissues representative of all three




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 58: Identification of trabecular bone in CGR8 teratomas.
Alizarin Red staining of 8 µm paraffin transverse sections of a CGR8 teratoma revealed
a region of tissue that exhibited calcium deposition, indicative of mineralisation in the
tissue. Haematoxylin and eosin staining revealed the structure of the mineralised tissue
was similar to trabecular bone with trabeculae containing calcium deposits. Scale bars
represent 100 µm. Bright-field images were taken using a Leica ICC50HD microscope






















































































































































































































































































































































A novel two-step culture technique of maintaining stem cell aggregates as 3D tissue-
discs using Alvetex®3D polystyrene scaffolds was investigated as a means to extend
the development potential of pluripotent stem cells in vitro.
4.1 Stem cell aggregates maintained using Alvetex®Polaris
developed into flattened tissue-discs.
Aggregates of TERA2.cl.SP12 and CGR8 cells that were cultured in suspension fol-
lowed by maintenance using Alvetex®Polaris developed into flattened tissue-discs.
TUNEL staining indicated that some aggregates maintained for extended periods in
suspension developed a necrotic core that resulted in large amounts of apoptosis and
reduced cell viability (Figure 11). In all the tissue-discs examined, however, no necrotic
core was detected and only a few scattered apoptotic cells could be identified. Tissue-
disc morphology reduced the distance of cells from the media and this may have pro-
tected against the development of a necrotic core by facilitating enhanced diffusion. It
has been reported that the oxygen concentration at the centre of large EBs (400 µm
radius) was 50% lower than at the center of small EBs (200 µm radius), supporting
the notion that flattened tissue-discs reduced apoptosis through enhanced diffusion
(Van Winkle et al., 2012). Tissue-disc cultures improve cell viability over prolonged
culture indicating their suitability to support long-term stem cell differentiation in
vitro.
Although scaffolds are being used more widely in the differentiation of PSCs, most
techniques involve seeding a single cell suspension into a scaffold that does not facil-
itate tissue-disc formation (Levenberg et al., 2003; Baharvand et al., 2006; Willerth
et al., 2006; Gerecht et al., 2007). EBs have been supported using hydrogels, but this
methodology also fails to support tissue-disc formation because the entire EB will be
supported and may not be as suitable for long-term culture due to limited nutrient
transport through the hydrogel (Kothapalli and Kamm, 2013). An alternative method
used thin pre-stretched electrospun polyurethane scaffolds to maintain spheroids of adi-
pose tissue-derived stem cells (ADSCs) (Beachley et al., 2014). Beachley et al. iden-
tified the ability of large tissue constructs to be assembled by joining smaller tissue
spheroids together. However, differentiation of ADSCs in tissue constructs was not ex-
amined. The principle of adhering smaller aggregates together on a thin scaffold mem-
brane to form a larger tissue construct could have uses in therapeutic tissue engineering
applications (Beachley et al., 2014). Interestingly, this method could be adapted and
EBs could be induced to distinct lineages and then combined in tissue-disc cultures to
generate complex tissues to study tissue interactions.
One study described a more similar protocol to ours: utilising Millipore mesh well-
inserts with a pore size of 0.4 µm to support hiPSC-derived serum free EBs (SFEBs)
cultured under neural inductive conditions (Nestor et al., 2013). Nestor et al. described
the ability of SFEBs maintainted in this way to flatten from 400 µm to 100 µm that fa-
cilitated live imaging and electrophysiological studies. They explained that the benefits
of 3D aggregation including enhanced cell:cell and cell:matrix interactions were main-
tained while minimising some of the drawbacks such as the requirement for disaggre-
gation prior to analysis. Millipore mesh well-inserts are a 2D raised platform that fa-
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cilitates tissue-disc formation while allowing aggregates to contact media at both their
apical and basal surfaces. Something that remains unexplored in the present study is
whether attachment to a 2D surface is equivalent to attaching to a 3D scaffold, if cells
are maintained within a 3D tissue-disc. Different strategies for tissue-disc maintenance
may have their own relative strengths and weaknesses. For example, Millipore mesh
well-inserts may be more useful for live-cell imaging studies of tissue-disc development,
while Alvetex®may be better suited to histological analyses.
4.2 Tissue-disc cultures facilitate the development of complex
tissues in vitro.
Aggregates of hEC cells and mEBs differentiated into complex tissues when maintained
as tissue-discs in vitro for extended periods.
TERA2.cl.SP12 cells formed neuroepithelial and non-neural epithelial tissues that ex-
hibited typical neural and epithelial marker expression when cultured as tissue-discs
using Alvetex®Polaris. TERA2.cl.SP12 cells have previously been shown to produce
neural and non-neural epithelial cell types upon spontaneous differentiation in 2D, as
aggregates in suspension, as aggregates maintained using Alvetex®, and as teratomas
(Przyborski et al., 2004; Hayman et al., 2004) and our findings confirmed their ability
to do so in 3D tissue-discs.
The tissues observed in hEC aggregates cultured as tissue-discs using Alvetex®Polaris
were comparable in complexity to those seen in aggregates cultured in suspension and
in certain cases more in vivo-like. Unfortunately, histological analysis of tissue-discs
was hampered by aggregates breaking up during tissue processing. A plausible expla-
nation is that the tissues shrank during ethanol dehydration more than the polystyrene
scaffold generating stress. If so, a way to overcome this problem in the future could be
to use OCT embedding and cryosectioning instead of paraffin embedding and section-
ing with a microtome.
Histological analysis indicated that CGR8 mESCs formed epidermis (keratin pearl),
neuroepithelium, cartilage, connective tissue, and endoderm-like epithelium when cul-
tured as 3D tissue-discs. It was challenging to identify the developmental origin of ep-
ithelial tissues because they could have represented any of several embryonic, extraem-
bryonic or adult tissues—a challenge that has previously been reported when identify-
ing EB-derived putative endodermal epithelial tissues (Sheridan et al., 2012). A con-
siderable repertoire of somatic cell types and tissues have been observed in EBs pre-
viously including neurons (Bain et al., 1995), adipocytes (Dani et al., 1997), chondro-
cytes (Kramer et al., 2000), muscle cells (Rohwedel et al., 1994), cardiomyocytes (Hao
et al., 2008), vascular endothelium (Wang et al., 1992), lymphatic endothelium (Liersch
et al., 2006), kidney (Vigneau et al., 2007), and intestinal epithelium (Konuma et al.,
2009). The array of cell types identified in EBs cultured as tissue-discs was not as ex-
haustive as this, but the small scale of this pilot study could be a primary reason for
this. Moreover, some of these cell types are only generated efficiently in isolation under
appropriate inductive conditions.
A number of studies have identified spontaneous development of small scale in vivo-like
tissues including neuroepithelial tissues, connective tissues, cartilage, and gut-like ep-
ithelial tissues in EBs maintained in suspension (Figure 60)(Doetschman et al., 1985;
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Itskovitz-Eldor et al., 2000; Sheridan et al., 2012). Tissues that developed in mEBs cul-
tured as tissue-discs such as endoderm-like epithelial tissues, connective tissues, and
neuroepithelial tissues were of a comparable complexity as tissue structures reported in
previous studies. Therefore this study demonstrates proof of principal for small scale in
vivo-like tissue development in long-term tissue-disc cultures. In further investigations
it may be possible to demonstrate convincingly that the tissues produced in tissue-
discs are more highly developed and in vivo-like in nature than those seen in suspen-
sion. This would require direct comparisons between EBs maintained in suspension and
maintained as tissue-discs for an equivalent time, however, which was not investigated
here.
4.3 Tissue-disc cultures can be used to study the role of de-
velopmental pathways in embryonic development.
The role of developmental pathways in embryonic development were examined in tissue-
disc cultures and stem cells could be directed towards specific lineages in a predictable
manner.
Despite being useful to study certain aspects of embryonic development, TERA2.cl.SP12
cells are not equivalent to hESCs or hiPSCs. Notably, expression of differentiated tis-
sue markers TUJ1 and CK8 was detected by immunocytochemistry in undifferentiated
TERA2.cl.SP12 cells in 2D culture (Figures 6, 7, and 8). TUJ1 was not detected in
a previous study by Western blotting in undifferentiated TERA2.cl.SP12 cells in 2D
(Stewart et al., 2003) and, therefore, it is possible that the expression detected here
reflects the high sensitivity of immunocytochemical detection and the cells may not
express these markers at biologically relevant levels. TERA2.cl.SP12 cells are a sub-
clone of the TERA2 lineage derived from a testicular teratocarcinoma lung metastasis
(Fogh and Trempe, 1975). It has been shown that TUJ1 is expressed in the testis and
in highly proliferative cancer cells and, therefore, TUJ1 expression in TERA2.cl.SP12
cells could also be due to their malignant testicular tumour origin. Interestingly, CK8
is the first cytokeratin to be expressed during embryogenesis (Magin et al., 1986) and
the propensity for TERA2.cl.SP12 cells to differentiate to epithelial tissues may suggest
that they occupy a developmentally restricted precursor state that expresses CK8 at
very low levels that is upregulated during differentiation. Despite limitations surround-
ing hEC cells, information about the role of signalling pathways in human embryonic
development was gained.
Retinoid pathway stimulation has previously been shown to induce neural differenti-
ation in a wide variety of PSCs including hECs and the data presented here agreed
(Tonge et al., 2010; Christie et al., 2010). Interestingly, neuroepithelial tissue develop-
ment was reduced in response to ec23 after 21 days suspension and 7 days culture using
Alvetex®Polaris. A plausible explanation for the altered morphology of ec23 treated
aggregates could be that early neuroepithelial progenitor states developed but were lost
more quickly under retinoid stimulation. It seems more likely, however, that a distinct
developmental pathway was being induced compared to the default neural development
seen in control TERA2.cl.SP12 aggregates.
TERA2.cl.SP12 cells were directed towards a non-neural fate by treatment with BMP2.























































































































































































































































































lial markers in TERA2.cl.SP12 cells in 2D and in aggregates maintained in suspen-
sion and our results reveal that tissue-discs responded in a similar manner (Horrocks
et al., 2003; Christie et al., 2008). Unexpectedly, neural differentiation was not en-
tirely blocked by BMP2 and one region of highly organised in vivo-like neuroepithe-
lium developed within a large hEC aggregate after 21 days BMP2 treatment (Figures
17&18). It was thought that this neural tissue could have developed due to production
of neural inhibitors such as noggin, but exogenous neural inhibition did not increase
neuroepithelial development in hEC aggregates (Section 3.3.3). It is possible that be-
cause the neural tissue was surrounded by mesenchyme and excluded from the media,
an hypoxic environment developed that has previously been shown to support neuroge-
nesis (Chung et al., 2014), or that the surrounding mesenchymal tissue provided some
form of nutritive support or other developmental cues that were neurogenic. Future
studies should try to elucidate the role of environmental factors such as oxygen tension
in neural induction in TERA2.cl.SP12 aggregates.
Unlike in hEC aggregates, in mEBs BMP inhibition promoted neurogenesis as has pre-
viously been reported (Zhou et al., 2010). This discrepancy supports the distinction
of hEC cells from ESCs and indicates the use of ESCs for determining the role of sig-
nalling pathways in development. Dorsomorphin has also been shown to induce my-
ocardial development when used at early timepoints in mESC differentiation which was
not performed here (Hao et al., 2008). The fact that cardiomyocyte differentiation ap-
peared to not occur in response to dorsomorphin reflects the stage-specific roles of sig-
naling pathways such as the BMP pathway during development.
Both TERA2.cl.SP12 and CGR8 aggregates cultured as tissue-discs responded in a
similar manner to canonical Wnt/β-catenin stimulation: Chi treatment reduced the
formation of epithelial cavities. One explanation for this is that exogenous Wnt ago-
nism by Chi was responsible for the considerable morphogenetic impacts seen in aggre-
gates. Canonical Wnt signalling is essential for primitive streak formation and main-
tenance during gastrulation and induces mesodermal derivatives (Arkell et al., 2013).
mEBs after 72h may have corresponded to this stage and been capable of responding
to Wnt/β-catenin stimulation by increasing mesodermal differentiation. Although ten-
tative, the results observed suggest that endodermal epithelial cavities were inhibited
but mesodermal connective tissues were not, possibly adding weight to this hypothesis.
In order to investigate this further, tissue-specific marker expression could be analysed
in Chi-treated mEBs to determine if mesodermal markers were upregulated in response
to Chi. TERA2.cl.SP12 cells are unlikely to recapitulate this developmental time frame
and so would not have responded in the same manner as mESCs. Another interpreta-
tion of the data is that the Wnt/β-catenin pathway plays a role in epithelial differentia-
tion in TERA2.cl.SP12 cells. Alternatively, the primary effect of Chi in hEC aggregates
could have been to block epithelial morphogenesis through GSK3β inhibition which has
previously been reported (Severson et al., 2010).
Unexpectedly, a significant proportion of mEBs failed to respond to exogenous devel-
opmental signals and developed in a similar manner to control aggregates. One possi-
bility is that the samples were confused during processing and human error is one ex-
planation. Similar experiments should be repeated and larger numbers of aggregates
examined in order to verify whether this was a real phenomenon. Human error seems
less likely an explanation, however, since similar results were found in both Chi- and
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dorsomorphin-treated mEBs that were processed separately. Another explanation could
be that a shell developed around those mEBs that failed to respond, preventing sol-
uble inducers in the media from entering mEBs and affecting differentiation. It has
been shown that EB morphology reduced passive diffusion of an inducer molecule by
up to 80% (Sachlos and Auguste, 2008), providing a mechanism whereby the addition
of soluble inducers to the media of mEBs cultured in suspension may be inefficacious.
The mEBs that did respond, however, were useful to examine and allowed insight to be
gained about the role of developmental pathways in murine embryonic development.
Human embryonic material has traditionally been limited by a lack of supply and eth-
ical concerns. Before the advent of hESCs and hiPSCs, hECs offered an alternative
model to study human embryonic development in vitro (Przyborski, 2001). In future
studies the ability of human EBs (hEBs) to be cultured as tissue-discs should be ex-
amined to allow human embryonic development to be studied in vitro. The study of
hEBs could facilitate improved directed differentiation outcomes to clinically relevant
cell types such as HSCs. However, there remain ethical concerns over the prolonged
maintenance of hEBs in culture. Even hiPSC-derived hEBs may fall under the remit of
embryo-like structures in certain cirmumstances—such as in gastruloid cultures—and
for this reason, maintaining hEBs beyond the primitive streak stage or for more than
14 days potentially constitutes an offence under current UK licensing laws (Baillie-
Johnson et al., in press, Human Fertilisation and Embryology Act, 2008).
4.4 Tissue-disc cultures offer an alternative in vitro pluripo-
tency assay.
Differentiation to tissues representative of all three embryonic germ layers was observed
in mEBs cultured as tissue-discs for up to 32 days and, therefore, tissue-disc cultures
offer a novel in vitro pluripotency assay.
Tissues seen in TERA2.cl.SP12 and CGR8 teratomas were larger, more complex, and
more diverse than those seen in tissue-discs cultured in vitro. This was expected be-
cause the in vivo environment provides nutritional support and developmental cues fa-
cilitating the differentiation of highly complex in vivo-like tissues (Przyborski, 2005).
Pluripotency testing, however, only requires the development of small scale tissues rep-
resentative of all three embryonic germ layers and in this regard tissue-disc cultures
were successful. What is not clear, however, is whether attachment to a 3D scaffold is
strictly necessary for this purpose.
Development of all three embryonic germ layers has been well characterised in human
(Itskovitz-Eldor et al., 2000) and murine EBs (Doetschman et al., 1985) and EBs main-
tained in suspension are frequently used as an in vitro pluripotency test that has been
suggested as a replacement for the teratoma assay (Sheridan et al., 2012). The fact
that tri-lineage differentiation is supported in EBs suggests that tissue-disc culturing
may be unnecessary. The more in vivo-like the tissue produced, however, the more
stringent the pluripotency test is. It is possible, therefore, that tissue-disc cultures may
provide a compromise between conventional in vitro differentiation in EBs and in vivo
differentiation in teratomas if long-term maintenance of EBs as tissue-discs provides an
opportunity to achieve differentiation outcomes beyond what is currently possible in
EBs maintained in suspension. Further work is required in order to demonstrate that
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more complex and in vivo-like tissues can be produced in tissue-discs compared to ag-
gregates cultured in suspension.
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5 Conclusions and Future Directions
The primary aim of this thesis was to investigate whether complex tissue development
is supported in 3D-cultured tissue-discs (aim 1). Neuroepithelium, epithelial cavities,
and mesodermal connective tissues were seen to develop, supporting this conclusion.
Flattened tissue-discs were hypothesised to increase cell viability over prolonged in
vitro culture compared to aggregates in suspension (aim 2). While increased viability
was observed, preliminary experiments must be repeated in order to validate this hy-
pothesis. Developmental signalling pathways such as BMP and retinoic acid signalling
were manipulated in aggregates and directed differentiation outcomes were achieved.
These data are in support of aim 3, therefore, suggesting that 3D culturing of pluripo-
tent stem cells can be used to study aspects of human embryogenesis.
The final aim was to investigate the utility of 3D tissue-discs as a novel in vitro pluripo-
tency assay (aim 4). Good evidence for ectodermal and mesodermal differentiation was
seen but endodermal tissues were not convincingly demonstrated. It seems likely that
with further experiments and through the use of genetic markers, tissue-discs could
be demonstrated to contain tissues representative of all three germ layers. With fur-
ther investigation 3D cultured tissue-discs may therefore offer an alternative to the
current gold standard teratoma assay. Further work should focus on determining the
advantages or disadvantages of using different (3D) substrates for tissue-disc formation.
Moreover, more cell types including EpiSCs, hESCs and hiPSCs should be investigated
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